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Background Resting heart rate (RHR) is an easily measured cardiovascular parameter that is 
considered an independent predictor of cardiovascular disease (CVD) and mortality in the 
general population. However, results on the association between RHR and these outcomes 
are inconsistent, and studies on longitudinal trends in RHR and the role of long-term changes 
in RHR in CVD and mortality are scarce. 
Objective To investigate secular trends in RHR in the general population of Tromsø, 
Northern Norway over the last decades, and to explore the role of RHR and long-term 
changes in RHR in CVD and mortality. 
Methods Participants from four surveys of the Tromsø Study conducted between 1986 and 
2008 were included in these analyses (n=34 751). RHR in these participants was measured 
with an automated Dinamap device and resultant data were linked to validated information 
on incident myocardial infarction, atrial fibrillation, ischemic stroke, cardiovascular death 
and total death. Statistical methods included mixed models analysis, fractional polynomials, 
and trajectory analysis. 
Main results Over 22 years of observation, the mean age-adjusted RHR declined from 73.4 
to 64.7 beats per minute in men, and from 78.3 to 66.4 beats per minute in women; 17.4% of 
the decline in men and 16.1% of the decline in women was attributable to favourable changes 
in other cardiovascular risk factors. In men, elevated RHR independently predicted the risk 
of myocardial infarction, atrial fibrillation, and cardiovascular death. In women, the 
associations with myocardial infarction and total death were similar to those in men, and we 
found a J-shaped association with ischemic stroke. Having a constantly elevated RHR or a 
RHR that increased from moderate to high over 15 years increased the risk of myocardial 
infarction, cardiovascular death, and total death in men, whereas estimates in women were 
insignificant. 
Conclusions Over the last decades RHR has declined substantially, and this decline has 
occurred to a large extent independently of other cardiovascular risk factors. RHR 
independently predicts the risk of CVD and mortality though there are sex differences. Long-
term changes in RHR provide additional information for risk assessment. Thus, RHR is as an 
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independent cardiovascular risk factor, and as such it should be monitored and used in risk 
assessments by both people themselves and by health professionals. RHR is a modifiable 





BMI – body mass index 
BP – blood pressure 
bpm – beats per minute 
CI – confidence interval 
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ECG – electrocardiography 
HDL – high-density lipoprotein  
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Chapter 1 Introduction 
In 2010-2011, a rough analysis of the data from the Tromsø Study showed that over the last 
few decades resting heart rate (RHR) has shown a remarkable decline in the general 
population. Between 1986-1987 and 2007-2008, RHR means dropped by approximately 10 
beats per minute (bpm); a little less in men and little more in women. These findings resulted 
in a project that aimed to describe and explain the decline in RHR, and to explore the role of 
RHR values in cardiovascular morbidity and mortality. 
I have always been interested in research, from my time as a medical student in Northern 
State Medical University, Arkhangelsk, Russia, and thereafter when I was working as a 
surgeon. Despite my interest, I lacked the knowledge and the opportunity to conduct a proper 
study. Soon I was able to enrol in a 2-year master’s program in public health at the 
International School of Public Health in Arkhangelsk. The program was based on the 
European model and taught by teachers from the University of Tromsø, and it finally gave 
me the opportunity I was waiting for: to learn how to conduct epidemiological studies, 
perform statistical analyses, work with real data, and write a scientific paper. I enjoyed 
statistics and epidemiology a lot, and that is why I became a co-teacher in these subjects. I 
was eager to continue with research and statistics after graduating from the International 
School of Public Health in Arkhangelsk. 
In June 2011, the day I defended my master thesis, I heard about the RHR PhD project. The 
topic itself was interesting and attractive to me both as a medical doctor and as a researcher. 
Moreover, the project was to include comprehensive statistical analyses, as well as 
opportunities to improve my skills, and to work in a high-level scientific environment with 
experts in the field. After a year and a half going through the application process, I was 
accepted as a PhD student at the Department of Community Medicine, the University of 
Tromsø, which is where the story between me and the decline in RHR in Tromsø begins. 
1.1 What this dissertation is about 
This dissertation is about RHR in the general adult population and is based on longitudinal 
data from the Tromsø Study, Northern Norway. This data was linked with validated follow-
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up information on cardiovascular disease (CVD) and mortality, which provided a unique 
opportunity to apply comprehensive statistical methods to thoroughly answer our research 
questions. This dissertation describes the downward trends in RHR in men and women from 
the general population of Norway over the last decades (Paper I). The decline was mostly 
independent: less than one-fifth of the decline was attributable to changes in cardiovascular 
risk factors other than RHR. The dissertation also shows that single RHR measures can 
independently predict the risk of CVD and mortality; moreover it demonstrates sex 
differences in these associations (Paper II). Elevated RHR gradually increases the risk of 
incident myocardial infarction, atrial fibrillation, cardiovascular mortality, and total mortality 
in men, and the risk of myocardial infarction, ischemic stroke, cardiovascular mortality, and 
total mortality in women. However, low RHR in women did not protect against ischemic 
stroke or cardiovascular death. This dissertation shows that long-term changes in RHR can 
provide additional prognostic information and are an independent predictor of myocardial 
infarction, cardiovascular mortality, and total mortality in men (Paper III). Mixed models 
analysis, fractional polynomials, and trajectory analysis were used to investigate the research 
question. 
1.2 Resting heart rate as a cardiovascular parameter 
RHR is defined as the number of heart contractions per minute while at rest,1 i.e., while a 
person is awake, in a temperate environment, and has not undergone any recent physical or 
psychological stimulation. In other words, RHR is the number of heart contractions needed to 
maintain basic body functions without any physical or psychological activity. Normal RHR 
in adults is between 60 and 90 bpm. However, people with a high physical activity level, for 
example professional sportsmen, usually have a RHR lower than 60 bpm. 
1.2.1 Measuring resting heart rate 
RHR as a clinical parameter has several advantages: it is fast, easy, and cheap to measure; it 
is easy to interpret; and it is understandable for both clinicians and patients. The 
measurement of RHR should be strictly standardised, as RHR can be influenced by many 
factors, such as resting period before measurement, environmental conditions, method of 
recording, number of readings, duration of measurement, a person’s posture, and the nature 
of the observer.2 To minimise the effects of these factors, exercise, alcohol consumption, 
3 
 
nicotine, and coffee consumption should be avoided for several hours before the 
measurement is taken. Before the first RHR measurement is taken, subjects should rest for at 
least 5 minutes in a quiet room at a comfortable temperature. Subjects should refrain from 
talking during the procedure. Although there are no objective data on whether one position is 
better than another, measurements of RHR taken in a sitting position are expected to be 1-2 
bpm higher than those taken in the supine position. Moreover, when comparing data from 
different sources, it is important to know the nature of the observer. Indeed, heart rate 
increases triggered by one’s alarm reaction to the measurement largely depends on this; heart 
rates tends to be higher when measured by a doctor, intermediate if measured by a nurse, and 
lower if measured by an automatic device in the absence of an observer.3 
The most frequently used methods used to measure RHR are: pulse palpation, 
electrocardiography (ECG), electronic devices, and oscillometry. Pulse palpation is used to 
measure pulse rate by the counting beats in a set time period (from 15 to 60 seconds) and 
multiplying that number to get the bpm. Pulse rates can be measured at the radial, carotid, 
brachial, and femoral arteries, as these arteries are close to the body’s surface. If stroke 
volume varies a lot (for example, in those with atrial fibrillation), some heartbeats can be 
missed at pulse palpation. In such cases, RHR can be measured directly by heart auscultation. 
ECG is the most precise way to measure RHR, but implies greater financial costs and may 
not translate into more meaningful data. RHR measurements from pulse palpation and from 
ECG are highly correlated (r>0.9) and provide similar information.4 
Electronic pulse meters consist of a transmitter placed over the artery and a receiver attached 
around the chest or a wrist watch receiver for display. A photo diode or a photo transistor is 
used to detect pulse rate.5 Infrared sensors are clipped to finger ends or ear lobes to detect the 
heart beat using plethysmographic technology. Simple heart rate monitors display pulse rate 
only. More professional monitors can record time, calculate average and maximum heart rate 
for a given period, and sound an alarm when a person reaches or exceeds a predetermined 
target zone. These electronic devices are usually accurate to within 3-4 bpm and are used 
mostly by athletes. 
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Oscillometry, or non-invasive automatic blood pressure (BP) monitors such as Dinamap, 
measure pulse rate and BP using an oscillometric method. This method is based on the 
principle that pulsatile blood flowing through an artery produces oscillations of the artery 
wall, which are transmitted to a cuff placed around the upper arm.6 This method has some 
advantages over pulse palpation and electronic devices, including lack of observer variation 
and increased accuracy. Pulse rates derived by the oscillometric method have been reported 
to be a valid indicator of heart rate.7 However, when compared to ECG, the oscillometric 
method measures actual peripheral pulses (pulse rate), not electrical signals or contractions of 
the heart muscles (heart rate). Thus differences may occur when cardiac electrical signals 
occasionally fail to produce a peripheral pulse. Differences may also occur in cases of 
varying stroke volume and/or poor peripheral perfusion. 
1.2.2 Regulation of resting heart rate 
In normal subjects, heart rate, and RHR in particular, is regulated by the pacemaker activity 
of the sinoatrial node cells, and constantly changes under the influence of many modifiable 
and non-modifiable factors.8 The sinoatrial node is innervated by vagus (parasympathetic 
fibres) that slows the heart rate and by sympathetic nervous thoracic efferents quicken the 
heart rate. When these effects are blocked by pharmacologic agents such as sympathetic 
antagonists (e.g., propranolol and metoprolol) and/or parasympathetic antagonists (e.g., 
atropine) we can identify the mechanisms of the autonomic regulation of heart rate. Blocking 
autonomic regulation completely (simultaneous administration of sympathetic and 
parasympathetic antagonists) allows us to measure intrinsic heart rate, that is, the basal rate 
of pacemaker cells. 
Non-modifiable factors that influence RHR include age (which is a matter of controversy, but 
some studies have reported a progressive decrease in intrinsic heart rate with age)9 and sex 
(women have a higher RHR than men).10 Physiological determinants of RHR are circadian 
cycle (lower during sleep compared with waking periods, mediated by neurohormonal 
factors)11, posture (lower in supine then in sitting position)12, and BP (positive association 
with both systolic and diastolic BP).4, 8 Modifiable factors that influence RHR include 
physical activity, mental stress, smoking, alcohol consumption, coffee consumption, and 
excess body weight. A number of studies have demonstrated that regular endurance physical 
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activity results in a reduction of RHR,13-16 which is mediated by a decrease in intrinsic 
rhythmicity, more predominant parasympathetic activity, and a slight decrease in the 
sympathetic contribution.16 Acute mental stress activates the sympathetic nervous system and 
triggers a consistent increase in plasma catecholamines, thereby increasing RHR and BP.17 
The acute effects of smoking include an increase in heart rate and BP,8, 18, 19 which is 
mediated by increased concentrations of plasma catecholamines and stimulation of peripheral 
adrenergic receptors. These acute changes persist at least for 30 minutes after smoking and 
occur again at each smoking episode.18, 20 Smoking also exerts long-term effects in that 
smokers have higher RHRs than non-smokers.21 The association between alcohol 
consumption and RHR is dose-dependent.8, 21 Moderate daily alcohol consumption decreases 
RHR, while heavier alcohol consumption causes a sustained increase in RHR and BP. Both 
coffee and caffeine acutely increase BP and decrease heart rate irrespective of the amount of 
daily caffeine consumption, caffeine intolerance, or smoking status.22, 23 As high calorie 
intake and obesity are associated with higher sympathetic activity, higher body mass index 
(BMI) was associated with higher RHR.8, 23 
1.3 Resting heart rate as a cardiovascular risk factor 
1.3.1 Epidemiological findings 
Unlike factors like elevated levels of total and low-density lipoprotein (LDL) cholesterol, 
low level of high-density lipoprotein (HDL) cholesterol, elevated BP, excess BMI, physical 
inactivity, smoking, and family history of heart diseases, RHR is not considered a traditional 
cardiovascular risk factor.24, 25 Although evidence on new parameters regarding their 
contribution to traditional cardiovascular risk assessment and traditional risk scores has been 
considered and is mentioned in some guidelines, RHR is not mentioned among the new 
potential parameters, such as cardiorespiratory fitness and high-sensitivity C-reactive protein, 
that could improve the prediction of CVD.24, 25 
One potential reason why RHR has not been considered a valid cardiovascular risk factor is 
that the findings on RHR as an independent risk factor are inconsistent. The role of RHR has 
been addressed in several large studies like the Framingham Study10 and the National Health 
and Nutrition Examination Survey (NHANES),26 in which RHR appeared to be a strong and 
independent predictor of cardiovascular morbidity and mortality. These findings correspond 
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with the results of several studies on RHR and cardiovascular death from other populations27-
30 and with the conclusions of two recent meta-analyses.31, 32 Another recent meta-analysis on 
RHR and CVD and non-cardiovascular disease morbidity showed that RHR independently 
predicted the risk of coronary artery disease, stroke, sudden death, and non-cardiovascular 
disease in the general population.33 However, some studies found no independent association 
between RHR and CVD when looking at both sexes combined34 or in women alone,35 
between RHR and coronary heart disease,36, 37 between RHR and mortality from coronary 
heart disease,38 or between RHR and stroke.39, 40 
Moreover, the majority of information on the association between RHR and mortality in the 
general population has come from observational studies. Thus, another potential reason why 
RHR is not considered an independent cardiovascular risk factor is the methodological bias 
associated with population-based studies. However, epidemiological studies “over history 
paved the way for translation of basic science into successful health interventions”.41 
1.3.2 Pathophysiological mechanisms 
The exact mechanism linking heart rate with CVD is still not clear. However, RHR has been 
shown to fulfil several of the criteria for causality.27, 42, 43 RHR is regulated by the autonomic 
nervous system, and the imbalance between sympathetic and parasympathetic activity is one 
of the important pathogenic components of CVD.44, 45 High RHR can disturb the balance 
between myocardial oxygen demand and supply.46 It has been suggested that heart rate can 
directly induce atherosclerosis through a local hemodynamic effect of pulsatory blood flow 
and turbulence on the arterial wall.45, 46 The pulsatile stress can provoke a proinflammatory 
response, though this adversely affects the vascular endothelium.45 Increased RHR is 
associated with increased systemic inflammation and endothelial dysfunction.47 Moreover, 
prolonged elevated RHR increases the risk of hypertension, and is associated with metabolic 
abnormalities. All these mechanisms contribute to the development and progression of 
coronary atherosclerosis, facilitate plaque destabilisation, and initiate arrhythmias, leading to 





1.3.3 Resting heart rate and other cardiovascular risk factors 
RHR correlates with other cardiovascular risk factors such as BP,27, 29, 44, 50, 51 physical 
activity,27, 50-52 atherogenic serum lipid fractions, especially triglyceride levels,27, 29, 50-53 body 
weight,27, 44, 52, 53 and smoking.27, 29, 52, 53 The presence of more than one cardiovascular risk 
factor increases the risk of having an elevated RHR.50 In the Tromsø Study, RHR was 
positively associated with smoking, total cholesterol, LDL cholesterol, and triglycerides, but 
inversely correlated with HDL cholesterol and physical activity level.52 The association 
between RHR and BMI was U-shaped. It has also been demonstrated that RHR is influenced 
by mental stress, job strain, alcohol consumption, and genetic determinants.8, 45, 54 
1.3.4 Trends in resting heart rate and other cardiovascular risk factors in the general 
population 
We found only a few studies that described RHR trends in the general population over the 
last decades. A study conducted on students of the Queen’s University Belfast, the United 
Kingdom (n=4508) showed a secular decline in RHR from 1949 to 1992 in both sexes, but 
showed an increase from 2001 to 2004.55 Another large population-based study from Paris, 
France (n=226 288) investigated RHR trends among middle-aged participants over 16 years 
(1992 to 2007).56 RHR declined by 5 bpm among men, and by 8 bpm among women. Both 
studies were carried out on cross-sectional data with no information about RHR changes on 
an individual level. Three studies from Norway demonstrated a decline in RHR over the last 
decades, although the main aim of these papers was not focused on RHR.57-59 None of the 
studies provided an explanation for the observed favourable trend in RHR. 
There have been substantial changes in traditional cardiovascular risk factors in the general 
population over the last decades.60-63 Total and LDL cholesterol,61-63 BP,61-66 and cigarette 
smoking60, 61, 63, 64, 66 have declined, whereas physical activity levels,64-66 BMI, the prevalence 
of overweight and obesity,56, 60, 62, 63, 67 and the prevalence of hypertension56 have increased. 
However, several studies observed different trends in these risk factors. A substantial 
decrease in BMI was seen over a 15-year period in Tallinn, Estonia, which was in line with 
the above-mentioned trends.64 A decrease in the proportion of physically active people and 
an approximately stable proportion of smokers was observed from 1992 to 2007 in Paris, 
France.56 A decrease in systolic BP and in the prevalence of hypertension between 1980-
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1982 and 1995-1997 were paralleled with less favourable trends in total cholesterol, 
hypercholesterinaemia, and physical activity in the state of Minnesota, United States of 
America (USA).60 
A recent paper based on data from the Tromsø Study aimed to estimate associations between 
trends in modifiable risk factors and a decline in acute coronary heart disease over the last 
decades.57 From 1994 to 2008 RHR declined in the general population, and this decline was 
accompanied by favourable trends in BP, total cholesterol, smoking, and physical activity. In 
contrast, BMI and the prevalence of diabetes mellitus increased in the population. All these 
trends in risk factors together accounted for 66% of the decline in the incidence of coronary 
heart disease; the decline in RHR accounted for 14.5% yielding to the decline in total 
cholesterol only. 
1.4 Cardiovascular mortality in the world and in Norway  
CVD is the leading cause of death worldwide.68 In 2013, one-third of all deaths globally 
(17.3 million out of 54.9 million deaths) were attributable to CVD. The majority of 
cardiovascular deaths (84.3%) were caused by ischemic heart disease and stroke. From 1990 
to 2013 the total number of cardiovascular deaths increased by 40.8%, mainly due to aging 
and population growth. However, age-standardised cardiovascular mortality rates from CVD 
fell by 22.0% between 1990 and 2013. Although mortality rates for ischemic heart disease 
and stroke fell (by 22.3% and 22.5%, respectively) during the same period, mortality rates for 
atrial fibrillation and flutter increased by 100.0%. This increase could be due to an increased 
awareness of atrial fibrillation or to better survival. 
Although cardiovascular mortality rates have declined dramatically in the world over the last 
decades, there are wide variations in the patterns of these rates between regions and 
countries. In high-income countries, age-standardised cardiovascular mortality rates fell by 
43% between 1990 and 2013, whereas the number of cardiovascular deaths did not change 
during this period.69 The decline in cardiovascular mortality rates was attributable to 
favourable changes in risk factors on a population level and to health care improvements. In 
contrast, in the same period in low- and middle-income countries, age-standardised 
cardiovascular mortality rates fell by only 13%, and the number of cardiovascular deaths 
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increased by 66%. The growth and aging of the population increased the proportion of 
cardiovascular deaths in low- and middle-income countries, and in 2013 this proportion was 
equal to that in high-income countries. 
There is also remarkable variation in cardiovascular mortality by country. Between 1985-
1989 and 2009-2012, cardiovascular mortality rates steadily declined in most European 
countries, with stronger declines observed after 1995-1999.70, 71 The situation is more dire in 
the Russian Federation and the former Soviet Union, where cardiovascular mortality rates 
were still extremely high and showed no clear tendency to decline by 2010.63, 70-72 In 
Norway, age-adjusted cardiovascular mortality rates decreased between 1991 and 2009, from 
430 to 194 deaths per 100 000 inhabitants in men, and from 240 to 129 deaths in women.73 
According to the updated rates from 2012 (179.4 and 117.2 cardiovascular deaths per 
100 000 inhabitants in men and in women, respectively), Norway has joined countries with 
the lowest cardiovascular mortality rates, including France, Portugal, and Spain.69, 71 There 
are several possible causes for these wide variations between countries, such as differences in 
dietary patterns and other risk factors, differences in healthcare systems, political 
governance, and resulting policy decisions.69 
1.5 Aims 
To investigate secular trends in RHR and other cardiovascular risk factors, as well as the 
associations between RHR and these factors is important if we are to interpret population 
changes in cardiovascular morbidity and mortality rates, predict the future burden of CVD, 
and design effective preventive measures.  
The overall aim was to explore secular changes in RHR using data from the Tromsø Study, 
which included a large study sample from the general population of Tromsø, Northern 
Norway from 1986 to 2008, and to explore the effect of RHR values on cardiovascular 
morbidity and mortality. This overall aim was separated into the following main research 
aims: 
• To describe secular changes in RHR in a large sample from the general population over 
a 22-year period (Paper I). 
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• To explore individual associations between RHR changes and changes in relevant 
cardiovascular risk factors and to estimate the contribution of changes in other risk 
factors to the decline in RHR (Paper I). 
• To investigate the effect of single RHR measures on the risk of incident myocardial 
infarction, incident atrial fibrillation, incident ischemic stroke, cardiovascular death, 
and total death in men and women (Paper II). 
• To identify long-term individual trajectories in RHR and to estimate their effect on the 
risk of incident myocardial infarction, incident atrial fibrillation, incident ischemic 
stroke, cardiovascular death, and total death in men and women (Paper III). 
• A secondary aim of this project was to apply new and comprehensive methods of 
statistical analysis, especially longitudinal data analysis (Papers I, II, and III). 
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Chapter 2 Materials and methods 
2.1 The Tromsø Study 
2.1.1 Settings, study design, and ethical considerations  
The city of Tromsø is the largest urban area in Northern Norway, the third largest city north 
of the Arctic Circle (following Murmansk and Norilsk), and the eighth largest municipality in 
Norway. The population has been increasing steadily, from 12 283 residents in 1960, to 
50 548 in 1990, to 72 681 in 2015.74 An excess of births has been a bigger factors than 
immigration in this population growth. More than 100 nationalities are represented in 
Tromsø; the more common minorities are the Sami, Russians, and Finns. The climate is 
subarctic. 
The Tromsø Study is a large, single-centre, population-based longitudinal study conducted in 
the Tromsø municipality. The study was initiated by the University of Tromsø in 1974, and 
its aim was to investigate the causes of the extremely high cardiovascular mortality in 
Northern Norwegian men.75 Later on, the focus of the study expanded to other chronic 
diseases, and included women as well. At present, six consecutive surveys of the Tromsø 
Study have been conducted: Tromsø 1 (1974, also referred as the Tromsø Heart Study, it 
included men only), Tromsø 2 (1979-1980), Tromsø 3 (1986-1987), Tromsø 4 (1994-1995), 
Tromsø 5 (2001-2002), and Tromsø 6 (2007-2008). 
Both whole birth cohorts and random samples of residents of the Tromsø municipality were 
selected for each survey based on the official population registry.75 New birth cohorts were 
successively added to the study population during Tromsø 1-4. Subjects that had been invited 
to a previous survey were invited to the following survey regardless of their attendance at the 
previous survey. In contrast to the other surveys, a larger proportion of those selected for 
participation in Tromsø 5 had participated in Tromsø 4. After adjustment for emigration and 
deaths, attendance rates were >80% in Tromsø 1-3, 77% in Tromsø 4, 79% in Tromsø 5, and 
66% in Tromsø 6. Attendance rates increased with age and were higher in women. 
The design of all Tromsø Study surveys was similar. Potential participants were sent an 
invitation, including information about the study and the examination, and a first 
questionnaire.75 Potential participants were allowed to attend whenever convenient within the 
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survey period, and one reminder was sent to non-attenders. The first questionnaire collected 
information on self and family history of CVD, physical activity, smoking, and ethnicity; it 
was completed at home and returned at the time of examination. All examinations were 
conducted by trained personnel according to standardised protocols, and included a review of 
the first questionnaire, physical examination, and blood sample collection. In Tromsø 2-6, 
participants were given a second, more comprehensive questionnaire at the time of 
examination. This questionnaire collected information on dietary habits, alcohol 
consumption, history of illnesses, social status, and physiological status; it was to be 
completed at home and returned by mail in a pre-addressed, stamped envelope. 
Approximately 90% of participants returned the second questionnaire. In Tromsø 4-6 a large 
proportion of participants were also invited to a second visit for a more extensive medical 
examination. 
The Tromsø Study was approved by the Data Inspectorate and by the Regional Committee 
for Medical Research Ethics, North Norway, and has therefore been performed in accordance 
with the ethical standards laid down in the 1964 Declaration of Helsinki and its later 
amendments. All participants in Tromsø 4-6 provided written informed consent. Participants 
are allowed to withdraw their consent or give a new one at any time. The invitation letters, 
questionnaires, consent forms, and thorough information about the data from the Tromsø 
Study can be found on the Tromsø Study website (www.tromsoundersokelsen.no). Direct 
weblinks to the invitation letters, questionnaires and informed consent forms for Tromsø 3-6 
are presented in the Appendix. 
2.1.2 Study population 
In the present study, we chose to use data from Tromsø 3-6, as RHR was measured the same 
way and by the same equipment in these surveys. Male and female participants of these four 
surveys who were 20 years of age or older at examination and provided informed consent 
were eligible for inclusion in the present study. As some of the participants did 
withdraw/give a new consent between 2011 and 2015, the number of participants with 
consent varied across the papers published over the period (Table 1). In all of the three 
papers, we excluded survey-specific information on those who were pregnant at the time of 
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examination and/or had missing RHR values. Other exclusion criteria differed across the 
papers. 
Paper I focused on RHR changes from 1986 to 2008, and therefore included information 
from Tromsø 3-6. To make the four surveys comparable by age, only those aged 30 to 89 
years at the time of examination were included. Therefore the subsample in Paper I 
comprised 30 699 participants (59 309 visits), 16 406 of whom attended two or more 
surveys. 
In Paper II we analysed associations between single RHR measures and risk of myocardial 
infarction, atrial fibrillation, ischemic stroke, cardiovascular death, and total death. As 
Tromsø 4 was the largest of the Tromsø Study surveys, it was chosen as the baseline survey. 
After exclusion of participants using BP treatment and those with missing information on 
cardiovascular risk factors, the final subsample for Paper II comprised 24 489 participants 
aged 25 years and older, 9086 of whom also took part in Tromsø 5 and/or Tromsø 6. 
Information on all of the considered variables was updated for participants who also took part 
in Tromsø 5-6, except for those who became pregnant and/or who started BP treatment. 
Paper III demonstrated associations between long-term individual trajectories in RHR and 
the risk of the outcomes mentioned above. Using data from Tromsø 3-5, but not Tromsø 6, 
allowed for a longer follow-up period. We excluded participants who reported that they had 
ever used BP treatment. We further excluded information from surveys at which a participant 
had missing values for any of the considered variables at that survey. In addition, we 
excluded participants who died or emigrated before 28 August 2001 (median of the Tromsø 5 
period – start of follow-up), and those who attended only one survey between Tromsø 3 and 
Tromsø 5. Following all exclusions, 14 208 participants (31 902 visits) aged 20 to 87 years 
were included in the subsample for Paper III. For more information on the subsamples used 
in Papers I-III see Table 1. 
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Table 1. Overview of subsamples of the Tromsø Study used in Papers I-III. 
 Sample size (n) and inclusion criteria 
 Paper I 
Resting heart rate 
decline 
Paper II 
Resting heart rate 
and endpoints 
Paper III 
Resting heart rate 
change and endpoints 
Number of participants 
before exclusionsa: 
- Tromsø 3 (1986-1987) 
- Tromsø 4 (1994-1995) 
- Tromsø 5 (2001-2002) 
























- Age (years) 
- Not pregnant  














Number of participants 
after exclusions: 
- Tromsø 3 (1986-1987) 
- Tromsø 4 (1994-1995) 
- Tromsø 5 (2001-2002) 























Endpoints information - + + 
aNumber of participants who provided informed consent by 5 December 2011 (data for Paper 
I) and by 11 August 2015 (data for Papers II and III) was different. bThose with missing 
values on RHR or other considered variables were excluded from all papers. cOut of 30 699 
participants, 14 293 attended only one of the four surveys, 7617 attended two of the surveys, 
5374 attended three of the surveys, 3415 attended all of the four surveys, and 16 406 attended 
at least two surveys. dOut of 24 489 participants of Tromsø 4, 9086 attended at least one of 
the subsequent surveys, and 2059 attended all the three surveys. eEvery participant attended 
at least two of the three surveys.
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2.1.3 Data collection and resting heart rate measurement 
Following standardised protocols, at each examination trained personnel reviewed the first 
questionnaire, performed a physical examination and collected blood sample. The first 
questionnaire provided different information depending on the survey. In Tromsø 3-6, it 
collected information about BP treatment use (yes/no), leisure time physical activity 
(sedentary, moderate, active, and very active), daily cigarette smoking (yes/no), history of a 
heart attack (yes/no), history of a cerebral stroke/brain haemorrhage (yes/no), history of 
diabetes (yes/no), coffee consumption (cups per day). In Tromsø 3-5 the first questionnaire 
collected information about current pregnancy (yes/no), in Tromsø 4-6 about alcohol 
consumption (times per month), and in Tromsø 5-6 about dietary habits. The second 
questionnaire provided information about current pregnancy in Tromsø 6, alcohol 
consumption (times per month) in Tromsø 3, and dietary habits in Tromsø 3-4. 
Weekly average leisure time physical activity for the last year was assigned to one of four 
levels according to following criteria:  
- Sedentary – reading, watching TV, or other sedentary activity; 
- Moderate – walking, cycling, or other forms of exercise at least 4 hours per week 
(include walking or cycling to work, Sunday walk/stroll, etc.); 
- Active – participation in recreational sports, heavy gardening, etc. (note: duration of 
activity at least four hours per week); 
- Very active – regular participation in hard training or sports competitions several 
times per week. 
Questions on leisure time physical activity were different in Tromsø 4 and for subjects 70 
years of age or older in Tromsø 5: how many hours per week (none, less than 1, 1-2, 3 or 
more) did you spend on 1) light activity (not sweating/out of breath), and 2) hard physical 
activity (sweating/out of breath). In order to correspond to the categories used in the other 
surveys, these answers were regrouped using an algorithm presented in Table 2.76 
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Table 2. Algorithm for regrouping of physical activity questions from Tromsø 4 and for 
those aged 70 years or older in Tromsø 5 into four levels76. 
Hours of hard 
physical activity 
per week 
Hours of light physical activity per week 
 None Less than 1 1-2 3 or more 
None Sedentary Moderate Moderate Active 
Less than 1 Moderate Moderate Moderate Active 
1-2 Moderate Moderate Active Active 
3 or more Active Active Active Highly active 
RHR and BP were recorded before blood sampling using an automated, non-invasive, 
microprocessor-controlled Dinamap device,77, 78 which uses the oscillometric method. 
Pulsatile blood flow through an artery produces oscillations of the artery wall that are 
transmitted to the Dinamap cuff around the upper arm.6 When the cuff pressure is higher than 
the systolic BP, the artery is occluded and few oscillations are transmitted to the cuff. When 
the cuff pressure is lower than systolic BP, the occlusion is partially released, and the 
pulsating blood flow produces oscillations in the cuff. When the cuff pressure falls below the 
diastolic BP and partial occlusion of the artery is relieved, oscillations are diminished. These 
devices inflate and deflate the cuff automatically. Results are displayed on the monitor. This 
work is controlled by a microprocessor. 
When switched on, the Dinamap device starts by pumping the cuff pressure up to 178 
mmHg. After this pump-up pressure is reached, the Dinamap begins a stepped deflation. It 
then determines systolic BP first, then mean arterial pressure, and then diastolic BP and pulse 
rate from oscillations induced in the cuff at the varied pressure levels. If a subject’s systolic 
BP exceeds the pump-up pressure (the absence of a systolic value), the Dinamap will stop 
deflation and re-inflate to a higher pump-up pressure (re-inflate maximum is 250 mmHg). 
The Dinamap deflates the cuff one step each time it detects two pulsations of relatively equal 
amplitude. If it is unable to find any pulse within 1.6 seconds, it will deflate to the next step. 
At each step, the microprocessor stores the cuff pressure, the matched pulse amplitude, and 
the time between successive pulses. The stepped deflation and matched pulse detection 
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continues until diastolic BP is determined or until the cuff pressure falls below 7 mmHg. 
Then the Dinamap deflates the cuff to 0 mmHg, analyses the stored data, and presents the 
results on a display. The maximum pulse rate detected by the monitor is 200 bpm, and the 
minimum is 40 bpm. For systolic and diastolic BP the maximum/minimum detected values 
are 245/30 mmHg, and 225/20 mmHg, respectively. 
The Dinamap Vital Signs Monitor 1846 (Critikon Inc, Tampa, Florida, USA) was used in 
Tromsø 3-5,79 and the Dinamap ProCare 300 (GE Medical Systems Information 
Technologies, Tampa, Florida, USA) was used in Tromsø 6.80 The devices were calibrated at 
regular intervals. The circumference of the upper right arm was measured and the proper cuff 
size was selected out of four available. After the participants had been seated for 2 minutes 
with the cuff on, three values were taken at 1-minute intervals.81 The mean value of the last 
two RHR measurements (in bpm) and of the last two BP measurements (in mmHg) was used 
in the present study. 
Body weight was measured with an electronic scale. Both body weight and height were 
measured with light clothing and no shoes, and were used to calculate BMI (kg/m2).75 Blood 
samples were used to determine non-fasting serum total cholesterol, HDL cholesterol and 
triglycerides (mmol/L). The analyses were carried out at the Department of Clinical 
Chemistry, Department of Medical Biology, University Hospital of North Norway, Tromsø.78 
2.2 Follow-up information 
Through the unique Norwegian personal identification number, the Tromsø Study 
participants can be linked to a variety of national and local registries, and can be followed up 
for a variety of outcomes. In present study participants were followed up for incident non-
fatal or fatal myocardial infarction, incident non-fatal or fatal atrial fibrillation, incident non-
fatal or fatal ischemic stroke, cardiovascular death, and total death throughout 2012. All 
cardiovascular outcomes were identified by linkage to the diagnosis registries at the 
University Hospital of North Norway (outpatient diagnoses included) and the National 
Causes of Death Registry, through a broad search for the International Classification of 
Diseases, Ninth Revision (ICD-9) codes 410-414, 427, 428, 430-438, and 798-799 and the 
ICD, Tenth Revision (ICD-10) codes I20-I25, I46-I48, I50, I60-I69, R96, R98, and R99. The 
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University Hospital of North Norway is the only hospital that serves the municipality of 
Tromsø; the next-nearest hospital is located approximately 250 km away by road (148 by 
air). The National Causes of Death Registry covers individuals registered as living in Norway 
at the time of their death, without regard to whether the death took place in Norway or 
abroad. 
Following a detailed protocol, an independent endpoint committee validated all possible 
events that were identified through the broad search. The committee retrieved all available 
hospital medical records for case validation. They performed manual searches in paper 
medical records (used until 2001) and electronic text searches of digital medical records for 
notes on all outcomes in all participants with one or more of the aforementioned ICD codes. 
Information from the National Causes of Death Registry and from death certificates was used 
to collect relevant information on fatal events from additional sources such as autopsy 
reports, nursing home records, ambulance services, and general practitioners. 
The definition and ascertainment of incident myocardial infarction was based on a 
classification algorithm which included clinical symptoms and signs, findings in 
electrocardiograms, values of cardiac biomarkers, and autopsy reports, when applicable 
(Paper II, Supplementary Table). In the present study, we included all incident myocardial 
infarctions classified as definite myocardial infarctions. Stroke was defined according to the 
World Health Organisation definition as rapidly developing clinical signs of focal or global 
disturbance of cerebral function, with symptoms lasting 24 hours or longer or leading to 
death, and with no apparent cause other than vascular origin. Strokes were classified as 
ischemic when brain imaging and/or autopsy had ruled out primary intracranial haemorrhage. 
ECG evidence of atrial fibrillation was required. Subjects with transient atrial fibrillation 
occurring only during acute myocardial infarction or in connection with a cardiac surgical 
procedure, and persons with atrial fibrillation documented only in the terminal phase of life, 
here defined as the last 7 days, were not classified as having atrial fibrillation. Participants 





2.3 Statistical analysis 
All analyses were sex-specific and were performed using the SAS program (SAS Institute, 
Cary, North Carolina, USA) versions 9.3 and 9.4. STATA/MP V.13.0 (StataCorp LP, 
College Station, Texas, USA) were used to calculate age-adjusted incidence rates. 
2.3.1 Paper I 
Descriptive statistical methods were used in Paper I to describe secular changes in RHR. 
RHR means were calculated in the four included surveys, in 10-year age groups and in 10-
year birth cohorts. We also calculated survey-specific means (standard deviations, SD) of 
RHR adjusted for age between sex and surveys using linear mixed models. 
Two approaches were applied to explore the associations between individual changes in RHR 
and changes in other cardiovascular risk factors. The first approach was to estimate the 
unadjusted association only. Individual changes in RHR between Tromsø 3 and Tromsø 4, 
between Tromsø 3 and Tromsø 5, and between Tromsø 3 and Tromsø 6 were calculated. The 
means of these individual changes were presented according to individual changes in other 
cardiovascular risk factors one by one. BP, blood lipids, and BMI were dichotomised into a 
survey- and sex-specific median split (yes/no for adverse/favourable level, respectively). The 
physical activity variable was dichotomised by collapsing sedentary and moderate physical 
activity levels into “into low physical activity” and active and highly active levels into “high 
physical activity”. For the binary variables there were four combinations of individual 
change between Tromsø 3 and each of Tromsø 4-6: no-no or yes-yes indicating favourable or 
adverse levels of a cardiovascular risk factor at both surveys, respectively; no-yes indicating 
change to adverse, or yes-no indicating change to favourable level of a cardiovascular risk 
factor. 
The second approach was to use data from Tromsø 3-6 as longitudinal, and to explore 
independent associations between individual changes in RHR and changes in other 
cardiovascular risk factors. Longitudinal studies are used to investigate the individual 
development of a certain outcome variable over time, and associations with individual 
development of other variables.82 In longitudinal studies, the outcome variable is repeatedly 
measured in the same individual over time. These repeated measurements are not 
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independent of each other, and therefore require a special type of statistical analysis to adjust 
for dependencies. In this study, the linear mixed models analysis was used to assess 
independent associations between individual changes in RHR and changes in other 
cardiovascular risk factors. 
The mixed models analysis (SAS Proc Mixed with the Repeated statement) has several 
advantages. First, it does not require complete data and allows the outcome variable to have 
missing values without affecting other scores from the same individual. Second, time can be 
continuous, rather than a fixed set of points. Third, possible dependencies between repeated 
measurements can be controlled for by selecting one of many covariance structures.  
In the repeated measures design, two measurements taken at adjacent time points are usually 
more correlated than two measurements taken several points apart.83 That is why it is 
essential to assess the covariance structure of the data. The mixed models analysis consists of 
two main steps: 1) estimating the covariance structure and 2) fitting the mean model to 
account for this covariance structure. The covariance parameters are estimated using 
likelihood-based methods (the restricted maximum likelihood by default). This method 
obtains estimates of parameters by minimising the likelihood of residuals from fitting the 
fixed effects portion of the model. 










210 ,  
where itY  represents measurements of the dependent variable for an individual i at time t, β0 
represents the intercept, Xij is the time-independent covariate j for individual i, β1j is the 
regression coefficient for time-independent covariate  j, J is the number of time-independent 
covariates, Zikt is the time-dependent covariate k for individual i at time t, β2k is the 
regression coefficient for time-dependent covariate k, K is the number of time-dependent 
covariates, t is time, β3 is the regression coefficient for time, and itε is the random error for 
individual i at time t (within subject covariance structure). 
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Only those who attended at least two of the Tromsø 3-6 surveys and did not have missing 
values on considered variables were included in the mixed models analysis. The dependent 
variable in the model was all subsequent values of RHR after the first attended survey. Time-
independent covariates were RHR value, values of other continuous cardiovascular risk 
factors, and physical activity level (four levels from sedentary to highly active) at the first 
survey attended, and year of first survey attended (1986, 1994, or 2001). Time-dependent 
covariates were year of subsequent survey (1994, 2001, or 2007), attained age, changes in 
other continuous cardiovascular risk factors and physical activity level, calculated as the 
difference between the subsequent and the first attended survey values, and change in BP 
treatment and smoking (quit, started, or continued, with ‘no’ to all as the reference). All 
continuous independent variables in the model, except age and RHR at first attended survey, 
were standardised. All continuous independent variables and physical activity variables were 
centred on their mean value. All the independent variables were included into the model at 
once, and therefore were mutually adjusted. The unstructured covariance matrix was used to 
adjust for possible dependencies between repeated observations, as it is the least restrictive of 
those available. The normality assumption in the linear mixed models analysis was assessed 
by visual inspection of the residuals. 
Mean RHR change from Tromsø 3 to Tromsø 6 adjusted for other cardiovascular risk factors 
was estimated as the difference between the intercept of the model (mean RHR at Tromsø 6 
whose first survey attendance was at Tromsø 3, and mean values or reference categories for 
other independent variables) and the RHR mean in Tromsø 3. 
2.3.2 Paper II 
In Paper II we intended to explore associations between single RHR measures and risk of 
incident myocardial infarction, incident atrial fibrillation, incident ischemic stroke, 
cardiovascular death, and total death. To visualise crude and age-adjusted associations we 
calculated sex-specific crude and age-standardised incidence rates as the number of events 
per 1000 person-years at risk by 10 bpm RHR groups. We applied direct standardisation 
using the weights from a reference population (men and women separately) to compute the 
weighted average of stratum-specific rate estimates in men and women. As the same 
reference population was used to compute directly standardised estimates for the 10 bpm 
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RHR groups, the resulting estimates can be compared between the RHR groups within each 
sex. 
Cox proportional hazards regression analysis with time-dependent covariates was used to 
analyse adjusted associations. However, there were several possible ways to include RHR, 
the independent variable of interest, into the model: as a continuous variable, as a categorical 
variable through “dummy variables”, and by using fractional polynomials. A continuous 
approach is easy to perform and to understand, but it is not able to reveal non-linear 
associations. A categorical approach is capable of that, but the results depend on the number 
and choice of cutoff points. Moreover, the results falsely postulate that risk suddenly changes 
as a category cutoff point is crossed and that there is homogeneity within each category. The 
fractional polynomials approach allows investigators to reveal associations of different forms 
by avoiding cutoff points. This approach is a simple, data-driven, flexible parametric method 
of modelling continuous risk factors.84 Fractional polynomials try out many different curves 
to find the function that best fits the data, which is then modelled in the main analysis. Thus, 
to analyse associations between RHR and each of the events, we used fractional polynomials 
of RHR adjusted for age in a Cox regression model. 
To prepare data for analysis, all participants with myocardial infarction, atrial fibrillation, 
and ischemic stroke before the date of inclusion (attendance of Tromsø 4) were excluded 
from event-specific analyses. Baseline RHR, as well as information about the other 
cardiovascular risk factors, was updated if a participant attended Tromsø 5 and/or Tromsø 6 
and was not pregnant, and/or not on BP treatment at the time of these surveys. Follow-up 
started at the date of baseline examination at Tromsø 4 and lasted until the date of the event 
of interest, date of death, date of emigration, or 31 December 2012, whichever came first. 
In sex- and endpoint-specific analyses, we used the following equation to find the best fitting 
fractional polynomials of RHR adjusted for age both first-degree and second-degree 
fractional polynomial Cox regression models: 
( )( ) ( )( ) AgebRHRbRHRbthth qp 3210lnln +++=  ( 02 =qRHRb for first degree models),  
where p and q were chosen from -2, -1, -0.5, 0, 0.5, 1, 2, and 3. Thus, 44 models with 
different combinations of powers (8 first-degree and 36 second-degree models) were fitted, 
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and sorted by the deviance. The deviance for each model has been subtracted from that of a 
straight-line model (baseline deviance): gain=baseline deviance – deviance for each model. 
Positive values of gain indicate an improvement in fit compared with the straight-line model. 
For each of the events, we chose the best-fitting fractional polynomials using the Akaike 
information criterion.85 The first-degree model with a highest gain was chosen over the 
straight-line model if its gain was ≥2. The second-degree model with the highest gain was 
chosen over the straight-line model and over the best first-degree model if its gain was ≥6, 
and 4 or more units higher than the gain for the best first-degree model. 
We ran sex-specific Cox regression analyses with time-dependent covariates to estimate 
hazard ratios (HRs) with 95% confidence intervals (CIs) for each of the five investigated 
events as a function of RHR and other cardiovascular risk factors. RHR was used as a 
continuous variable modelled according to the best fitting fractional polynomials form. We 
estimated HRs for RHRs of 50, 60, 80, 90, and 100 bpm, using 70 bpm as the reference 
value, using following formula: 
( ) ( )( )qqpp xbxbHR 77exp 21 −∗+−∗= , 
where x represents the RHR value divided by 10, 7 is the reference RHR of 70 bpm divided 
by 10, b1 and b2 are regression coefficients for RHR in the second-degree model, p and q are 
degrees in the second degree model. HRs were adjusted for age only, and then for age, 
systolic BP, total cholesterol, HDL cholesterol, triglycerides, BMI, physical activity, and 
smoking, simultaneously. Likelihood ratio tests between a model with and a model without 
fractional polynomial terms of RHR were used to test the associations. The proportional 
hazard assumption was verified by comparing log minus log of survival curves between RHR 
groups. 
2.3.3 Paper III 
In Paper III we aimed to explore associations between long-term changes in RHR and risk of 
incident myocardial infarction, incident atrial fibrillation, incident ischemic stroke, 
cardiovascular death, and total death. We had up to four measurements of RHR per subject 
over the 22-year study period (Tromsø 3-6) and follow-up information on the endpoints of 
interest throughout 2012. The simplest way to analyse the data would have been to calculate 
individual changes in RHR between Tromsø 3 and Tromsø 4, and include this RHR change 
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into the Cox regression model. However, if we had done this we would have lost the RHR 
information from Tromsø 5 and Tromsø 6. Instead, we applied trajectory analysis (SAS Proc 
Traj), which allowed us to use RHR information from more than two surveys, and therefore 
gave a more comprehensive picture of long-term changes in RHR. For the sake of longer 
follow-up, we ran SAS Proc Traj using RHR information from Tromsø 3-5, but not from 
Tromsø 6, and then included identified RHR trajectories in the Cox regression analysis as a 
predictor. 
Trajectory analysis (SAS Proc Traj), or latent class models analysis, is designed to identify 
distinct clusters of individuals, called trajectory groups, who have followed a similar 
developmental trajectory on a variable of interest over time or age.86 The program assumes 
that there are multiple trajectory groups in the population, and fits longitudinal data as a 
discrete mixture of two or more latent trajectories via maximum likelihood. Proc Traj 
estimates a regression model for each discrete trajectory group within the population. Proc 
Traj does not provide any individual-level information on the pattern of time change; 
subjects are grouped, and it is assumed that every subject in the group follows the same 
trajectory.87 
The latent class trajectory function can be specified as follows: 
( ) ititjitjitjjit xxxy εββββ ++++=∗ 332210 ,  
where each trajectory is represented by a latent variable, ( )∗ity , which is the predicted score of 
the outcome variable y for a given trajectory j at a specific time t; itx , 
2
itx , and 
3
itx  represent 




2β , and 
j
3β are the 
intercept and slopes for a trajectory j; itε  is an error tern assumed to be normally distributed 
with a mean of 0 and a constant SD.88 
SAS Proc Traj, created by Dr. Bobby Jones, is not part of the standard SAS® program and 
must be downloaded. The Proc Traj files were downloaded from Dr Jones’ website 
(http://www.andrew.cmu.edu/user/bjones) and copied to the folders on a hard drive as 
directed on the website. Using SAS Proc Traj, long-term RHR trajectory groups were derived 
among participants who attended at least two surveys between Tromsø 3 and Tromsø 5. The 
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censored normal distribution was used for modelling RHR trajectories, as it is appropriate for 
continuous dependent variables. The year of the survey was used as the time period scale. 
Using the Bayesian Information Criterion, we tested models with one, two, three, four, five, 
and six potential trajectories, all in a quadratic form. The final model had five trajectory 
groups as it fit better than the models with fewer groups, and because increasing the number 
of trajectory groups led to small group sizes. We compared the model fit of models with five 
groups with different functional forms (linear or quadratic), but kept all of the five trajectory 
groups with up to quadratic order terms, as this model was a more sensible representation of 
the data.89 The posterior predicted probability of belonging to each of the five RHR trajectory 
groups was calculated for each individual, and individuals were assigned to a trajectory 
group based on the highest posterior probability. We named the trajectory groups to describe 
their visual patterns. 
The number (proportion) of participants in the five RHR trajectory groups was calculated. 
RHR means were plotted according to the three surveys and the RHR trajectory groups. 
Descriptive characteristics of the RHR trajectory groups were presented as means (SD) and 
numbers (proportions). Means and percentages were adjusted for age between the surveys 
and the RHR trajectory groups using linear mixed models or generalised estimating 
equations, respectively. 
Cox regression analysis was used to estimate associations between belonging to a certain 
RHR trajectory group and the risk of each investigated outcome. In the analysis of morbidity 
endpoints, we excluded those who had had the event of interest or had moved from Tromsø 
before the start of follow-up. We calculated HRs and their 95% CIs for each RHR trajectory 
group, using the low RHR trajectory group as a reference. HRs were adjusted first for the 
mean age across the surveys alone, and then for the mean values of age and other 
cardiovascular risk factors (systolic BP, total cholesterol, HDL cholesterol, triglycerides, 




Chapter 3 Results – Summary of papers 
3.1 Paper I “Resting heart rate on the decline: the Tromsø Study 1986-2007” 
According to Tromsø 3-6, RHR did not differ with age, and was higher in women than in 
men. Between 1986 and 2008, mean RHR values declined by approximately 9 bpm in men, 
and 11 bpm in women. RHR declined in all 10-year age groups and in all birth cohorts. The 
age-adjusted RHR means decreased from 73.4 (SD 13.0) bpm to 64.7 (SD 10.9) bpm in men, 
and from 78.3 (SD 12.6) bpm to 66.4 (SD 10.3) bpm in women. More than half of this 
decline occurred between Tromsø 5 and Tromsø 6. 
Univariate analysis showed that RHR declined gradually from survey to survey in all 
subjects regardless of any individual changes in other cardiovascular risk factors. However, 
the decline in RHR was more pronounced in those who changed from the adverse to the 
favourable level of BP, blood lipids, BMI (in men), smoking, and physical activity (in men) 
than in those who changed in the opposite direction or did not change. RHR declined in all 
subjects regardless of their change in BP treatment status, except for six men who stopped 
taking medication during the study period. The decline was less pronounced in those who 
took BP treatment throughout all the surveys. 
When estimated by the linear mixed models analysis, the mutually-adjusted decline in RHR 
over the study period was 7.19 (95% CI 6.74 to 7.64) bpm in men and 9.99 (95% CI 9.54 to 
10.44) bpm in women. Compared to the age-adjusted RHR decline (see above), 17.4% of the 
decline in men and 16.1% of the decline in women was attributable to individual changes in 
other cardiovascular risk factors. The strongest predictor of the RHR decline in both men and 
women was a decline in triglycerides. Thus, a 1-SD more pronounced decline in triglycerides 
was associated with a more pronounced decline of 1.65 bpm in RHR in men, and with a more 
pronounced decline of 1.27 bpm in RHR in women, compared to the estimated RHR decline 
(see above), which was estimated for a person with the mean change in triglycerides. Other 
strong independent predictors of individual decline in RHR were high initial physical activity 
level and increase in physical activity over time, decrease in systolic BP, change in smoking 
status, and a decrease in BMI in men; and initiation of BP treatment, low initial systolic BP, 
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decrease in systolic BP over time, and change in smoking status in women (arranged in 
decreasing order of the association strength). 
3.2 Paper II “Resting heart rate predicts incident myocardial infarction, atrial 
fibrillation, ischemic stroke, and death in the general population: the Tromsø Study” 
In men, both crude and age-adjusted incidence rates of myocardial infarction, cardiovascular 
mortality and total mortality increased gradually with RHR, while the association with atrial 
fibrillation was U-shaped. In women, incidence rates of all the cardiovascular events were 
elevated at both low and high RHR levels, resulting in U-shaped associations of RHR with 
myocardial infarction and total mortality, and J-shaped associations of RHR with atrial 
fibrillation, ischemic stroke, and cardiovascular mortality. 
Cox regression analysis with RHR modelled according to the best-fitting fractional 
polynomials showed that the risk of myocardial infarction, atrial fibrillation, cardiovascular 
mortality, and total mortality in men increased gradually with RHR in both age-adjusted and 
mutually-adjusted models. Mutually-adjusted HRs of myocardial infarction, atrial 
fibrillation, cardiovascular mortality, and total mortality for a RHR of 100 bpm compared to 
70 bpm were 1.16 (95% CI 1.04 to 1.30), 1.21 (95% CI 1.03 to 1.43), 1.77 (95% CI 1.49 to 
2.10), and 1.72 (95% CI 1.52 to 1.94), respectively. In women, the associations were similar 
for myocardial infarction (even stronger than in men), cardiovascular mortality, and total 
mortality, with HRs for a RHR of 100 bpm compared to 70 bpm of 1.37 (95% CI 1.13 to 
1.66), 1.63 (95% CI 1.33 to 2.00), and 1.55 (95% CI 1.39 to 1.73), respectively. However, in 
women we revealed a U-shaped association of RHR with ischaemic stroke: the adjusted HR 
for a RHR of 50 bpm was 1.31 (95% CI 0.90 to 1.90) and the adjusted HR for a RHR of 100 
bpm was 1.32 (95% CI 1.04 to 1.69), with a RHR of 70 bpm as a reference. The positive 
association between RHR and atrial fibrillation diminished after adjustment for other 





3.3 Paper III “Long-term resting heart rate trajectories and myocardial infarction, 
atrial fibrillation, ischemic stroke, cardiovascular and total death in the general 
population: the Tromsø Study” 
Five discrete long-term RHR trajectories were identified among participants who attended at 
least two surveys between Tromsø 3 and Tromsø 5: low RHR trajectory (those who 
maintained low RHR in Tromsø 3 through Tromsø 5), moderate RHR trajectory (those who 
maintained moderate RHR), decreasing RHR trajectory (those who started with high RHR 
and experienced a decrease to moderate RHR), increasing RHR trajectory (those who started 
with moderate RHR and experienced an increase to high RHR), and elevated RHR trajectory 
(those who had elevated RHR throughout). Out of 6898 men, 22.4% were in the low RHR 
trajectory group, 53.9% in the moderate trajectory group, 11.0% in the decreasing trajectory 
group, 10.1% in the increasing trajectory group, and 2.7% in the elevated trajectory group. In 
women (n=7310) the corresponding proportions were 24.6%, 58.6%, 8.6%, 6.9%, and 1.3%. 
Among men and after adjustment for age, being in the moderate, decreasing, increasing or 
elevated RHR trajectory groups was associated with a gradually elevated risk of myocardial 
infarction compared to the low RHR trajectory group. However, only the increasing and the 
elevated RHR trajectory groups independently predicted myocardial infarction compared to 
the low RHR trajectory group: HRs were 1.36 (95% CI 0.95 to 1.95) and 1.83 (95% CI 1.11 
to 3.02). Among women, associations between RHR trajectories and risk of myocardial 
infarction were similar to those in men, but adjusted HR did not reach significance. No clear 
association was found between RHR trajectories and risk of atrial fibrillation or ischemic 
stroke neither in men nor in women. In men, when compared to the low RHR trajectory, risk 
of cardiovascular death was independently increased in the increasing (HR 1.86; 95% CI 
1.11 to 3.11) and elevated RHR trajectory groups (HR 1.94; 95% CI 0.95 to 3.96). Risk of 
total death gradually increased from the low to the elevated trajectory groups with HRs of 
1.26 (95% CI 1.02 to 1.56) for the moderate, 1.37 (95% CI 1.03 to 1.82) for the decreasing, 
1.82 (95% CI 1.40 to 2.38) for the increasing, and 2.44 (95% CI 1.69 to 3.53) for the elevated 
RHR trajectory groups. We did not reveal associations between RHR trajectories and risk of 




3.4 Additional results 
Some of the results were mentioned in the papers, but data were not shown. Figure 1 
demonstrates the decline in RHR we observed among those who attended, and had their RHR 
recorded, at all four surveys. Figure 2 demonstrates RHR means between Tromsø 3 and 
Tromsø 6, in 10-year age groups and in 10-year birth cohorts among those who attended only 
one of the surveys. The degree and the pattern of decline in RHR in these groups were 
similar to the main results presented in Paper I. Figure 3 describes in detail the five RHR 
trajectory groups used in Paper III. Both individual values and RHR means in the trajectory 
groups are presented by sex. 
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 Figure 1. Resting heart rate means in those who attended all the surveys under study (Tromsø 
3-6, n=3415), the Tromsø Study, 1986-2008 
 
 
a. By birth cohort and Tromsø Study survey 
                                                                                                             Birth cohorts: 
     
b. By age (years) and Tromsø Study survey                                                                                                                                                             
                                                                                                                                    Age: 
 
                                     Men                                                                        Women 
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Figure 2. Resting heart rate means in those who attended one of the surveys under study 
(Tromsø 3-6, n=10 951), the Tromsø Study, 1986-2008 
 
 
a. By birth cohort and Tromsø Study survey                         
                                                                                                                            Birth cohorts: 
 
b. By age (years) and Tromsø Study survey                                              
                                                                                                                           Age: 
 
 
                                          Men                                                                                 Women 
 
RHR means for those aged 60-79 years at Tromsø 5 (n=15) and those born between 1915 and 1924 at Tromsø 
6 (n=11) are not presented due to small sample size. 
32 
 
Figure 3. Individual values and means (blue triangles) of resting heart rate (RHR) by trajectory 
groups in men and women, the Tromsø Study, 1986-2001 
1. Men 
a. Low RHR trajectory group in men 
 
 




Figure 3. Individual values and means (blue triangles) of resting heart rate (RHR) by trajectory 
groups in men and women, the Tromsø Study, 1986-2001 (continued) 
 
c. Decreasing RHR trajectory group in men 
 
 




Figure 3. Individual values and means (blue triangles) of resting heart rate (RHR) by trajectory 
groups in men and women, the Tromsø Study, 1986-2001 (continued) 
 









Figure 3. Individual values and means (blue triangles) of resting heart rate (RHR) by trajectory 
groups in men and women, the Tromsø Study, 1986-2001 (continued) 
 
b. Moderate RHR trajectory group in women 
 
 




Figure 3. Individual values and means (blue triangles) of resting heart rate (RHR) by trajectory 
groups in men and women, the Tromsø Study, 1986-2001 (continued) 
 
d. Increasing RHR trajectory group in women 
 
 
e. Elevated RHR trajectory group in women 
 
Bpm: beats per minute 
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Chapter 4 Discussion 
4.1 Methodological considerations 
4.1.1 Study design 
This observational study clearly had the potential to answer the research questions stated in 
the study aims (see 1.4). The study design we used is located toward the top of the hierarchic 
scale of study designs, following systematic reviews and randomised control trials. Although 
systematic reviews are considered the best study design for getting precise estimates and 
drawing reliable conclusions, there are certain disadvantages associated with them, such as 
heterogeneity, loss of information on important outcomes, and inappropriate subgroup 
analyses.90 Moreover, there are not many studies published on RHR changes over time, and 
none of them included longitudinal information. Randomised control trials would not be 
relevant for studying secular changes in the general population. 
The Tromsø Study is a prospective, observational, population-based study conducted on 
large representative samples from the general population of the municipality of Tromsø.67 
The Tromsø Study cohort is open, and participants can leave or be added to the cohort over 
time. We used information from Tromsø 3-6. The fact that many, though not all, participants 
attended more than one of the these surveys makes the study longitudinal. The main 
advantage of longitudinal studies over cross-sectional ones is that the outcome variable is 
measured repeatedly, and the development of this outcome among individuals can be 
explored over time.82 Thus, a longitudinal study design with a 22-year study period in a 
combination with appropriate statistical techniques is a proper way to explore RHR decline 
in the population in Tromsø 3-6 (Paper I). This approach also allows to update RHR values 
when studying associations between RHR and cardiovascular morbidity and mortality (Paper 
II), and to investigate and define long-term RHR trajectories in Tromsø 3-5 (Paper III). 
Linking the Tromsø Study data to the diagnostic registries at the University Hospital of North 
Norway, the National Causes of Death Registry, and the Population Register of Norway 
through the unique Norwegian personal identification number makes this study a proper 
cohort study (Papers II and III). None of the participants had the outcome of interest at the 
beginning of the follow-up period (we excluded those who did using information from the 
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registries). Those participants who attended several surveys had their baseline information 
updated during the follow-up period (Paper II). The study cohort was followed up to 2012 for 
the outcome of interest (Papers II and III). Finally, the incidence rates of the outcome of 
interest were compared between groups with different exposure variables. This large 
population-based cohort study is an appropriate study design to answer questions about RHR 
(Paper II) and long-term individual changes in RHR (Paper III) as risk factors for CVD and 
mortality. 
4.1.2 Selection bias, response rate, and loss to follow-up 
Selection bias is a systematic error that can occur during the recruitment of study subjects. 
When such bias occurs, the results of the study may not be applicable to the general 
population of interest, as the participants may not be representative of this population. The 
Tromsø Study is a population-based study. To assure that the study sample was 
representative of the Tromsø population, entire birth cohorts, as well as random samples of 
other age groups from the Tromsø municipality were selected and invited based on the 
official population registry.67 Thus, the main possible source of selection bias in the Tromsø 
Study is non-responders, or non-attendees.  
The participation rate in the Tromsø Study was relatively high: >75% in Tromsø 3-5 and 
66% in Tromsø 6 (adjusted for emigration and deaths). Although selection bias is usually not 
a big concern in large population-based studies with a high participation rate, some 
differences between attendees and non-attendees could still lead to selection bias. For 
example, attendees, especially those who attended several surveys, were more concerned 
about their health, and could therefore be healthier than people in the general population. 
This could result in a steeper downward trend in RHR in our Tromsø Study participants than 
in the general population. Compared to the Tromsø Study participants, non-attendees were 
younger, more often men and more often single.67 It is not possible to compare attendees and 
non-attendees by other parameters, but findings from Tromsø 1 showed that participants who 
returned the second questionnaire after examination were remarkably similar to those who 
did not with regard to BP, blood lipids, and BMI.91 Baseline characteristics of those who 
attended Tromsø 192 and Tromsø 393 were similar among those who did and did not 
participate in subsequent Tromsø Study surveys. 
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With respect to the endpoints, in cohort studies there is a possibility of differential loss to 
follow-up. To be differential, subjects who are lost to follow-up should be different from 
those who remained under observation in respect to the exposure of interest (RHR in Paper 
II, long-term changes in RHR in Paper III) and to the outcome of interest. If subjects who are 
lost to follow-up tend to have different risks for the outcome of interest, then only incidence 
estimates will be biased. If the possibility of being lost to follow-up is different with respect 
to the exposure of interest, then relative measures of association will be biased. In this 
dissertation, loss to follow-up is not a major concern because of the unique Norwegian 
personal identification number, which allows for linkage to national and local registries. The 
University Hospital of North Norway is the only hospital serving the Tromsø municipality. 
The National Causes of Death Registry covers individuals registered as living in Norway at 
the time of their death, without regard to whether the death took place in Norway or abroad. 
The Population Register of Norway contains information on those who emigrated from 
Tromsø. Even though there were still some losses to follow-up in our study, they were 
unlikely to be related to RHR or to the endpoints, and therefore are unlikely to be differential. 
4.1.3 Information bias 
The long study period is one of the main advantages of this study, but it is also one of the 
concerns. The study comprises data from the four Tromsø Study surveys conducted between 
1986 and 2008 with a break of between 6 to 7 years between surveys. During the 22 years of 
observation, some changes in questionnaires and measuring techniques did occur. This is an 
issue of reproducibility, as, although most of these changes were favourable (improved due 
to scientific and technical progress), they could affect RHR values as well as the values of 
other variables. This is a potential source of measurement bias, or differential 
misclassification. In this study, differential misclassification means that the probability of 
being misclassified differs across the surveys, which could affect long-term changes in RHR 
and other variables. 
During the four surveys RHR and BP were measured by the same Dinamap device, with a 
new model being introduced in Tromsø 6. In parallel, the most notable decrease in RHR 
occurred between Tromsø 5 and Tromsø 6. However, the difference in the accuracy of the 
pulse rate measurement between the two Dinamap models used was only 0.5%, which could 
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not explain the substantial decline in RHR we found.79, 80 Moreover, RHR means declined 
from Tromsø 3, through Tromsø 4, to Tromsø 5, surveys during which the same Dinamap 
model was used. Finally, a study that aimed to evaluate accuracy of different non-invasive 
automatic BP monitors showed that the readings given by instruments using the oscillometric 
method were accurate and reproducible.6 
The personnel responsible for RHR and BP measurements also changed during the study 
period. However, all of the surveys used trained female nurses who followed a standardised 
protocol. Moreover, changes in personnel could not cause a differential bias or result in the 
downward trend in RHR that we observed. It is very unlikely that newly-employed survey 
nurses would gradually underestimate RHR. The same logic can be applied to the rooms 
where these measurements were recorded, including temperature, space, colour of the walls, 
etc.  
Although all of the examination procedures in Tromsø 3-6 were conducted according to 
standardised protocols, in Tromsø 6 participants underwent a cold water immersion test 
before RHR and BP measurements were taken. It is again unlikely that this test caused the 
differences in RHR that we observed across the surveys, as it usually results in an increase in 
RHR;94 moreover, participants had time to rest after the test. Finally, RHR went down 
between Tromsø 3 and Tromsø 5 as well. 
The fact that information on physical activity, smoking, BP treatment, diet, coffee 
consumption, and alcohol consumption was self-reported and that blood tests were non-
fasting could also result in misclassification. People can, intentionally or unintentionally, 
under- or overestimate their physical activity level, misreport their smoking status or use of 
BP treatment, or underestimate their alcohol consumption. Non-fasting levels of blood lipids 
are influenced by the type and amount of food consumed, and the time since their last meal. 
All these potential measurement errors are most likely non-differential with respect to 
comparisons between the surveys (especially when these questions were asked in the same 
way), but they can be differential in respect to CVD and mortality. 
According to mass media and the Tromsø Study paper on trends in modifiable cardiovascular 
risk factors, physical activity level increased in the Tromsø population over the last decades. 
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It reflects new culture, with more training facilities and more people who train.57, 95, 96 Similar 
trends can be seen in Norway though there are some discrepancies between the studies.97 
Taking into account the strong negative association between physical activity level and RHR, 
one can suggest that this new culture is the explanation for the decline in RHR we observed. 
Nevertheless, our results showed that only a small part of the RHR decline was attributable to 
individual changes in physical activity. The question on leisure time physical activity in the 
Tromsø Study questionnaire was introduced by Saltin and Grimby almost 50 years ago and 
has been widely used in population-based studies ever since.98 It was validated against 
various measures. However, instruments that measure a physical activity must not only be 
valid and reliable, but also sufficiently sensitive to detect relevant changes in patterns of 
habitual physical activity level. Objective instruments, such as fitness testing or devices to 
assess movement directly, are usually more sensitive than questionnaires,99 but they are not 
yet common in large epidemiological studies due to their cost and the burden they place on 
respondents. A self-reported instrument such as the Tromsø Study questionnaire may not be 
sensitive enough to reveal modest, but clinically meaningful, changes in physical activity. 
There is sparse evidence on the responsiveness to change of common instruments used to 
measure physical activity. Reeves et al. compared the responsiveness to change of three self-
reported measures of physical activity within the context of a broad-reach intervention 
trial.100 The authors concluded that brief self-reported measures (2 walking for exercise items 
from the US National Health Interview Survey; and the 6-item Active Australia 
Questionnaire) are as responsive to change as more-detailed measures (the 31-item 
Community Health Activities Model Program for Seniors). Cleland et al. assessed the ability 
of the Global Physical Activity Questionnaire to detect changes in physical activity.101 Levels 
of agreement with objective measurements indicated that the questionnaire was a valid 
measure of change in moderate-vigorous physical activity, but a less valid measure of change 
in sedentary behaviour. 
Moreover, the physical activity question in our study was able to reveal changes in the 
duration and probably in the intensity of physical activity, but not in the type or frequency of 
the activity. Analysis was limited to leisure time physical activity, although physical activity 
at work may result in less physical activity in leisure time. Knowing these facts it is still 
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possible that individual change in physical activity played a more important role in the RHR 
decline than we were able to reveal. 
The question on physical activity in Tromsø 4, and partly in Tromsø 5, was asked differently. 
Although we regrouped the physical activity levels to correspond to the other surveys, the 
figures in these surveys were quite different from those in other surveys. This could have led 
to a differential under- or overestimation of physical activity level at Tromsø 4, and partly at 
Tromsø 5, compared to other surveys, but this would not have affected the overall downward 
trend in RHR we observed over the study period. 
4.1.4 Learning effect and sample attrition 
Due to the longitudinal nature of our study, a learning effect may have occurred. A learning 
effect occurs when individual measurements can be influenced by a changing attitude toward 
the measurement itself.82 A learning effect can be positive or negative. RHR is a flexible 
cardiovascular parameter that is influenced by many external parameters, such as 
psychological atmosphere, air temperature, light, wall colour, etc. For example, due to test 
effect, a reduction in the white-coat phenomenon and/or a better awareness among the 
participants may have made them more relaxed during subsequent surveys, thus lowering 
their RHR. This is a potential “negative learning effect” that could have contributed to the 
RHR decline we observed. However, time periods between the surveys were too long to 
make this theory plausible. Moreover, RHR means of those who attended only one of 
Trosmø 3-6 went down over the study period as well (Figure 2). 
Sample attrition is another potential methodological problem in longitudinal studies that 
could contribute to the decline in RHR. Participants with an adverse cardiovascular risk 
profile, including high RHR, might have died before the subsequent survey. However, in our 
study the cohort was open, and new people were invited to the surveys, and the RHR decline 
was still of the same magnitude and was present in all age groups, including young people, 
who are less likely to die. Moreover, when only those who attended all of Tromsø 3-6 were 




4.1.5 Age, time, and cohort effects in longitudinal studies 
In longitudinal studies aiming to explore individual changes over time, each measurement of 
a variable of interest on each subject at a particular time point is influenced by at least three 
factors: age, period, and birth cohort.82 The corresponding effects of these factors are referred 
to as age effects, period effects, and cohort effects, and they must be separated from each 
other to answer the research question. In this study, RHR changes over time were of interest. 
The RHR measurement for each subject at each survey could be influenced by the age of the 
subject at the survey, by the survey itself, and by the subject’s year of birth. The aim was to 
find out whether the RHR decline was due to a period effect, or if it was confounded by age 
and/or birth cohort effects. A period effect would then be explained by other covariates, such 
as the development of other cardiovascular risk factors, and/or specific environmental 
conditions, and/or changes in measurement methods over time, etc. 
The multiple longitudinal design, in which repeated measurements are taken in more than 
one cohort with overlapping ages, is most suitable for studying the development of a variable 
on an individual level,82 and the Tromsø Study fits these criteria. Thus, it was possible to 
distinguish the period effect from the age and cohort effects. As different cohorts were 
measured at the same time points it was possible to separate period effects from cohort 
effects; and as several age groups were measured at the same time points it was possible to 
separate period effects from age effects. To check whether the RHR decline was due to a 
period effect, all three variables: age, year of survey, and birth year were plotted against each 
other (Paper I, Figure 2). According to the results, the RHR decline was mostly due to the 
period effect, with almost no effect of age or birth cohort. 
4.1.6 Confounding and interaction 
Confounding is a situation in which the association between an exposure and an outcome 
variable is observed as a result of the influence of a third variable or several variables.102 In 
cohort studies, a confounder is a third variable that is unevenly distributed between exposed 
and unexposed participants and is casually associated with the outcome. Potentially, the 
associations between RHR changes and changes in other cardiovascular risk factors over 
time (Paper I) could be confounded by variables such as age, diet, socioeconomic 
characteristics, climate change, etc. The associations of RHR (Paper II) and RHR change 
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(Paper III) with CVD and mortality could be confounded by cardiovascular risk factors and 
other variables. 
Effects of age, BP, blood lipids, BMI, smoking, physical activity, and BP treatment on RHR 
change were mutually adjusted in the mixed models analysis (Paper I). The effect of RHR 
(Paper II) and RHR trajectories (Paper III) on CVD and mortality were adjusted for the other 
cardiovascular risk factors in multivariate Cox regression models. We did not have detailed 
information on treatment, such as type of drugs that interact with RHR, or doses, to properly 
adjust for this variable in Papers I and II. That is why subjects who used BP treatment were 
excluded from the analyses. There were other characteristics that could be potential 
confounders, but they were not measured in the study or were measured differently from 
survey to survey, which made it difficult/impossible to adjust for them. Such potential 
confounders were heart rate variability, physical fitness, markers of inflammation, trans fats 
in food and other dietary features, alcohol consumption, coffee consumption, mental stress, 
and quality of life. 
Interaction is a situation when two or more covariates mutually modify their effects on the 
outcome variable.102 When there are theoretical or clinical suspicions, it is recommended to 
check for an interaction effect between independent variables. Variables that most often 
interact with biological and health-related parameters are sex and age. We stratified all the 
analyses by sex and presented results separately for men and women. In order to check and to 
deal with the possible interaction between age and RHR, we stratified RHR means by 10-
year age groups. RHR went down in all age groups, and downward trends were fairly similar 
across age groups. 
Another variable that could be considered as a potential effect modifier is BP treatment, 
which was self-reported. Details on the type of drugs that interact with RHR and their doses 
were not available. However, excluding those taking BP treatment from the analysis had 
virtually no effect on the downward trend in RHR (Paper I). When only those on BP 
treatment were considered, the downward trend in RHR disappeared. For the same reasons 
we excluded those taking BP treatment from the analyses with follow-up information (Papers 
II and III). 
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4.1.7 Statistical analysis 
Keeping in mind the unique longitudinal data we have in the Tromsø Study, one of the 
unspoken aims of this project was to probe novel and comprehensive statistical methods to 
answer the research questions. Many epidemiological and clinical studies are being 
conducted worldwide, and more and more data, including longitudinal data, are available for 
answering different research questions. The Tromsø Study consists of six repeated surveys 
conducted from 1974 to 2008, and Tromsø 7 is almost complete, providing an opportunity to 
explore long-term trends in cardiovascular risk factors and many other health-related 
characteristics, to explore associations between the development of these characteristics over 
time on an individual level, and their effects on different outcomes. Thus, new elaborate 
methods of statistical analysis are needed to properly adjust for dependencies of repeated 
measurements within a subject, to be able to reveal different shapes of associations between a 
continuous predictor and outcome, to take into account the time-dependency of a variable, 
and finally to reveal common long-term trajectories of a parameter with repeated 
measurements. 
In order to decide on how to analyse multilevel, or hierarchical data, one should distinguish 
between clustered data, repeated measures, and longitudinal data.103 In clustered data, the 
dependent variable is measured only once per subject, but the subjects are somehow 
clustered; and there is no ranking of subjects within clusters. In repeated measures data, the 
dependent variable is measured more than once per subject, and these measurements are 
taken under different conditions (a separate independent variable). In longitudinal data, the 
dependent variable is measured several times per subject over a certain, relatively long time 
period, and time itself is an important independent variable. Missing observations or dropouts 
is one of the main challenges in longitudinal studies, and data can be both clustered and 
longitudinal at the same time. 
Three main approaches can be used to analyse such multilevel data: repeated measures 
multivariate ANOVA/GLM, the marginal multilevel model (generalised estimated 
equations), and the linear mixed models.104 ANOVA, or multivariate approach is usually 
used for analysing repeated measures data. Multiple measurements are included in the 
analysis as multiple dependent variables. This method is conceptually simple, but has many 
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assumptions, such as balanced design and equal correlation among dependent variables. It 
does not allow post-hoc tests for the repeated measures factor. 
In the marginal level model there is only one dependent variable, and another variable 
indicates the condition or time of a measurement. In the marginal model, the correlations 
among each subject’s residuals can be estimated directly. There are several common patterns 
that residuals can correlate. For example, an auto-regressive structure, in which some 
repeated measurements are closer to each other than others (over either time or space), has 
higher correlations. This could be relevant for longitudinal data, but is not an issue for purely 
clustered data. In a situation when the assumptions of equal variances and equal correlations 
are not met, a marginal model is preferred over repeated measures multivariate ANOVA. 
Another advantage is the possibility to perform post-hoc tests for the repeated measures 
factor. 
Similar to the marginal model, the linear mixed models control for dependency between 
observations, but in a different way. It adds one or more random effects for subjects to the 
model in the form of additional residual terms with estimated variances. The mixed models 
are flexible and can handle both clustered data and repeated measures in one model. Another 
advantage is that data can be unbalanced. 
We tried several options when analysing the associations between single RHR measures and 
the outcomes. RHR as a main predictor was included in the Cox regression analysis as a 
continuous and as a categorical variable with different cutoff points. The continuous 
approach would not allow us to reveal non-linear associations, and the categorical approach 
was fraught with many subjective decisions on RHR categorisation, which had an effect on 
the results. Finally, it was decided to apply fractional polynomials. This approach allowed us 
to reveal possible non-linear associations and to use RHR in a continuous form. This method 
also provided the possibility to derive risk estimates for extremely low and extremely high 
RHR values. Using the Cox regression analysis with time-dependent covariates allowed us to 
update RHR and other risk factors whenever it was possible. 
Finally, we applied statistical analyses that allowed us to identify detailed RHR trajectories 
during the 15-years of observation. One way to construct categories of developmental 
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trajectories for more than two repeated measurements was to assign these categories based on 
subjective criteria. Although this method is reasonable, there are some important limitations, 
such as an a priori assumption of the existence of distinct developmental trajectories. 
Moreover, an individual’s group membership cannot be quantified in the form of 
probabilities.86 The trajectory analysis has the capacity to identify qualitatively distinct 
developmental progressions and to distinguish variations due to chance from real differences 
across individuals. As recommended, in order to choose the number of trajectories in the 
final models, we used both a careful weighting of formal statistical criteria against 
explanatory power and usability in the analyses.86 Figure 3 demonstrates clearly that the 
trajectory analysis managed very well to assign individuals to the five trajectory groups. 
4.2 Discussion of main results 
4.2.1 Secular trends in resting heart rate 
This study found that in the 22 years from 1986 to 2008, RHR means declined in the general 
population of Tromsø, Norway by approximately 9 bpm in men, and 11 bpm in women. 
Later, and based on the same Tromsø Study data, Mannsverk et al. reported that the age- and 
sex-adjusted proportion of those with an RHR of 80 bpm or higher declined from 30% (95% 
CI 29 to 31) in Tromsø 4 to 11% (95% CI 10 to 11) in Tromsø 6.57 The National Health 
Screening Service has been offering regular cardiovascular risk factor screening to men and 
women aged 40-42 years from all Norwegian counties except Oslo since 1985. The National 
Health Screening Service reported a decline in RHR from 72.5 bpm in 1994-96 to 70.6 bpm 
in 1997-99 in men and from 76.7 bpm to 74.9 bpm in women.58 Another recently published 
study from Norway, the Nord-Trøndelag Health Study, showed that from 1984-86 to 2006-08 
RHR means declined from 74.9 (SD 12.6) to 70.2 (SD 11.5) in men and women from the 
general population aged 20 years and older.59 
A substantial decline in RHR has also been described in general populations from other 
countries.56, 105 The NHANES carried out in the USA collected RHR data in 1971-75 
(NHANES I) and 1999-2008 (NHANES 1999-2008) in order to report and update 
population-based reference ranges for different age groups.105 Mean RHR values declined 
from 78.6 bpm to 70.0 bpm in White men aged 25-74 year during NHANES I, and among 
those 20 years and older during NHANES 1999-2008. The comparable RHR values in 
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women declined from 81.0 bpm to 74.5 bpm. Although the authors explained the difference 
in RHR between the two surveys by systematic differences in methodology, I think the 
decline in mean values of 8.7 bpm in men and of 6.5 bpm in women over the three decades is 
too pronounced to be explained by a change in measuring technique. A downward trend in 
RHR values has also been reported in Paris, France,56 where RHR means declined between 
1992 and 2007 by 5 bpm in men and by 7 bpm in women of all ages (mean age 44.7 years, 
SD 12.7) from the general population. 
The first published study on RHR trends was conducted on first-year students (16-24 years) 
of Queen’s University Belfast, United Kingdom.55 From 1949 to 1992 RHR means declined 
by 9 bpm in men and 10 bpm in women. However, from 2001 to 2004 RHR means increased 
by 5 bpm in men and 8 bpm in women. This J-shape pattern does not correspond to our 
results, or to the results of the studies mentioned above. However, participants in the study 
from the United Kingdom were younger and the sample size smaller. Moreover, the authors 
mention that the values from 2001 could be influenced by the fact that recruitment after 2001 
was voluntary. 
Although the methodology of the studies on RHR trends in general populations was different 
(aims of the studies, recruitment procedures, cross-sectional or longitudinal design, RHR 
measurement technique), all the studies, with the exception of the study from the United 
Kingdom,55 demonstrated a consistent and substantial decline in RHR values in both men and 
women over the last decades. In general there is a perception that low RHR is associated with 
a healthy lifestyle and therefore a lower CVD risk compared to elevated RHR, and many 
studies have confirmed that.44, 106, 107 RHR is modifiable, and people with a higher physical 
activity level, lower BP, and non-smokers have a lower RHR. Thus, when one hears about a 
decline in RHR over the last decades, one may believe strongly that it is due to BP treatment, 
increased physical activity, and/or a lower proportion of smokers in society. Although 
positive trends in BPPaper I, 57-59, blood lipids,Paper I, 56, 57, 59 physical activity,Paper I, 57, 59 smoking 
cessation,Paper I, 57, 59 and BP treatmentPaper I, 57, 59 are present in populations, none of the above-
mentioned studies proved that the decline in RHR could be explained by changes in 
traditional cardiovascular risk factors. 
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The two Norwegian studies that reported a decline in RHR focused on decline in BP.58, 59 
However, as RHR and BP are correlated, the reasons behind the decline in both RHR and BP 
could be similar. Tverdal et al. found no reasonable explanation for the decline in BP, but the 
cross-sectional study design and absence of information on most of the other cardiovascular 
risk factors would not allow for that.58 The authors confirmed that the BP decline was not 
related to methodological aspects. 
Holmen et al. analysed the data on BP and other cardiovascular risk factors from 74 549 
participants, 27 605 of whom attended all the three Nord-Trøndelag Health Study surveys 
conducted in 1984-1986, 1995-1997, and 2006-2008.59 Thus, the authors were able to look at 
the individual associations between change in BP and change in other cardiovascular risk 
factors. When restricting the analysis to those who reported they had never taken BP 
treatment, the authors found that the observed diastolic BP decrease was associated with 
increased age, decreased BMI, decreased total cholesterol, and decreased RHR in both men 
and women. The fact that individual decreas in BP was associated with individual decreas in 
RHR led the authors to conclude that a possible explanation for both could be increased 
parasympathetic activity. One of the suggested explanations was a reduction in the white coat 
phenomenon. In my opinion, though it could be partly true, the white coat phenomenon 
cannot explain such a substantial decline in RHR or BP. Indeed, we analysed data from 
participants who attended only one Tromsø Study survey, and we observed a similar decline 
in RHR (Figure 2). 
The study from Paris had cross-sectional data and could not analyse associations between 
change in RHR and change in other parameters on an individual level, so they used 
stratification.56 The authors concluded that the decline in RHR they observed could not be 
accounted for by traditional cardiovascular risk factors, including physical activity and CVD 
treatment. Similarly, Black et al. concluded that RHR trends in students could not be 
accounted for by physical activity or smoking status.55 We had longitudinal data, a large 
amount of participants who attended two or more of the Tromsø 3-6 surveys, and 
comprehensive information on other cardiovascular risk factors, and we found that only one-
fifth of the decline we observed was attributable to individual changes in other 
cardiovascular risk factors and BP treatment (Paper I). 
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Thus, none of the studies that reported a decline in RHR in the general population over the 
last decades could find the reasons behind this trend. However, it is debatable whether such 
epidemiological studies are able to find the explanation. RHR varies a lot within individuals, 
even during the day, and is highly dependent on many internal and external factors as well as 
interactions between them. Moreover, not all the factors can be properly measured in large 
samples, and not all the factors can be measured on an individual level. One possible 
explanation could be changes in diet and eating patterns.Paper I, 59 
Diet, alcohol consumption, and coffee consumption influence RHR and other cardiovascular 
risk factors (Paper I). Over the last decades dietary habits in Norway have changed 
substantially: energy intake and consumption of trans fats, potatoes, and eggs have 
decreased, while consumption of fruits, vegetables, cereals, fish, meat, cheese, unsaturated 
fat, and potassium have increased.Paper I, 59 However, it is difficult to prove whether these 
changes could have caused the decline in RHR we observed, especially on an individual 
level. We did analyse associations between change in RHR and change in some of the dietary 
variables, alcohol consumption, and coffee consumption, but we did not find any 
associations. This could be because information on diet was self-reported and was asked 
differently from survey to survey. We also found that an individual decrease in blood levels 
of triglycerides was the strongest predictor of RHR decline in both men and women. Non-
fasting levels of triglycerides are influenced by food eaten recently, and therefore could 
approximate dietary habits (Paper I). On the other hand, population-based dietary and 
lifestyle interventions could explain the non-linearity of the RHR decline we observed (Paper 
I). It could also explain why the RHR decline in France occurred several years earlier,56 as 
some positive dietary changes were applied there earlier (Paper I). 
Plichart et al. suggested that the decline in RHR could be a consequence of environmental 
changes such as outdoor temperature and pollution.56 Unfortunately, it is difficult to measure 
such exposures on an individual level, especially over long periods. Air concentrations of 
ozone (O3), nitrogen dioxide (NO2) and sulfur dioxide (SO2) can influence cardiac 
autonomic function, but Norwegian trends of these concentrations were not consistent with 
the RHR trends we found (Paper I). 
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Decreases in emotional, cognitive, and physical stress levels in society could be another 
possible explanation for the decline in RHR we observed. Mental stress results in an 
autonomic imbalance, increased sympathetic activity, and plasma catecholamines, thereby 
increasing the heart rate.8 Job strain and low job control have also been shown to be 
associated with elevated RHR.54 Stress level may have decreased in society over the last 
decades, resulting in the RHR decline, but we do not have data to confirm this. 
4.2.2 Resting heart rate as a cardiovascular risk factor 
RHR is not considered a traditional cardiovascular risk factor, and it is not part of the 
cardiovascular risk assessment in American or European guidelines.24, 25 However, RHR 
levels have declined in the general population over the last decades,Paper I, 56, 58, 59, 105 and this 
trend was accompanied by changes in other cardiovascular risk factors and a decline in 
cardiovascular morbidity and mortality. The key question is: is RHR an independent 
predictor of CVD and should it be considered a separate cardiovascular risk factor? Although 
many studies have been conducted on the association between RHR and CVD and mortality, 
the results were inconsistent.37 We had data that could potentially overcome the limitations of 
previous studies and found that elevated RHR independently increased cardiovascular risk, 
while low RHR had a protective effect on the risk of incident myocardial infarction, incident 
atrial fibrillation, cardiovascular death, and total death in men. In women, elevated RHR 
independently increased the risk of myocardial infarction, ischemic stroke, cardiovascular 
death, and total death; however low RHR values had no protective effect in relation to 
ischemic stroke and cardiovascular death (Paper II). 
The association between RHR and incident myocardial infarction, atrial fibrillation, and 
ischemic stroke in the general population has not been well investigated or described in the 
literature. We found a strong, independent, positive gradual association between RHR and 
incident myocardial infarction in both men and women, and it was stronger in women than in 
men (Paper II). There are few studies on the association between RHR and myocardial 
infarction, but those that do exist are in agreement with our findings, especially in women.27, 
39, 40 A recently published meta-analysis based on 30 cohort studies (1 227 511 participants 
and 18 364 cases) that used coronary artery disease as an outcome demonstrated the mutually 
adjusted relative risks by category of RHR (<60 bpm – reference category, 60-70 bpm, 70-80 
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bpm, and >80 bpm) of 0.99 (95% CI 0.93 to 1.04), 1.08 (95% CI 1.01 to 1.16), and 1.30 
(95% CI 1.19 to 1.43), respectively in both men and women from the general population.33 
The independent risk of coronary artery disease increased significantly by 12% for every 10 
bpm increment in RHR. As myocardial infarction is one of the major components of 
coronary artery disease and shares the same pathogenesis (coronary atherosclerosis and 
myocardial ischemia), these figures correspond well to our findings. 
A recently published study based on Tromsø Study data estimated that 66.1% (95% CI 47.6 
to 96.8) of the decline in the incidence of acute coronary heart disease from 1995 to 2010 
was accounted for by trends in modifiable cardiovascular risk factors.57 The decline in RHR 
over the study period contributed 14.5% (95% CI 6.9 to 24.0); 13.6% (95% CI 6.3 to 24.1) in 
men and 17.6% (95% CI 1.5 to 45.2) in women. The only cardiovascular risk factors that 
contributed to the decline in coronary heart disease incidence more than to the decline in 
RHR were total cholesterol in both sexes and systolic BP in women. 
Elevated heart rate contributes to an imbalance between myocardial oxygen demand and to a 
decrease in coronary blood supply.46 Experimental evidence supports the role of heart rate in 
endothelial dysfunction, atherosclerosis progression, and plaque rupture, resulting in 
coronary thrombosis.46, 108, 109 Based on these considerations, it is plausible that elevated 
RHR is an independent and self-sufficient risk factor for coronary heart disease, and 
myocardial infarction in particular. Thus, several criteria for validating RHR as a risk factor 
for myocardial infarction are fulfilled: plausibility (pathophysiological mechanisms), 
strength, and gradation of the association. 
Our findings of a positive, gradual association between RHR and atrial fibrillation in men (in 
women the association was weaker and insignificant) contradict other population-based 
studies that reported an increased risk of atrial fibrillation in those with low RHR.110-112 This 
inconsistency may be explained by the ascertainment of the outcome, lone atrial fibrillation 
(Paper II). Lone atrial fibrillation is defined as the occurrence of atrial fibrillation before the 
age of 60/65 years in the absence of underlying disorders such as hypertension, heart failure, 
myocardial infarction, valvular heart disease, diabetes, and hyperthyroidism. The underlying 
mechanism for lone atrial fibrillation is different from that of atrial fibrillation with the 
53 
 
underlying conditions.Paper II, 113 In our study, only a small proportion (6%) of the participants 
had lone atrial fibrillation. O’Neal et al. included participants aged 65 years or more and 
found an increased risk of general atrial fibrillation in those with an RHR of 60 bpm or 
lower.111 However, RHR was measured by wrist palpation, and ascertainment of atrial 
fibrillation was different, meaning that cases of non-permanent atrial fibrillation could have 
been missed, which was noted by the investigators. Participants taking BP treatment were not 
excluded from the analysis. 
One recent paper based on the same Tromsø Study data showed opposite results, i.e., that the 
risk of atrial fibrillation increased with decreasing RHR.112 The adjusted HR for each 10 bpm 
increase in RHR was 0.92 (95% CI 0.86 to 0.98), and an RHR of less than 50 bpm was an 
independent risk factor for atrial fibrillation compared to an RHR of 60 bpm or higher. The 
authors were intrigued by the fact that RHR and physical activity had a different relationship 
with atrial fibrillation (they found J-shaped association between physical activity and risk of 
atrial fibrillation with the lowest risk at moderate activity levels). In my opinion, these two 
Tromsø Study-based papers showed different results because Morseth et al. did not exclude 
participants who reported BP treatment as we did. Instead, Morseth et al. adjusted for BP 
treatment in the models. Participants talking BP treatment are at a higher risk of atrial 
fibrillation, as hypertension is an important risk factor. At the same time, some of these 
medications affect RHR. Detailed information on treatment (type of drugs or doses) was not 
available to properly adjust for this variable, so we excluded participants taking BP treatment 
at baseline and did not update information for those who started to take these medications at 
later surveys. Our results for atrial fibrillation were not stable when including those on BP 
treatment at baseline in the analysis and adjusting for BP treatment, or when only updating 
information on those who started to take medications later and adjusting for BP treatment. 
Data from the Copenhagen ECG study demonstrated a J-shaped association between RHR 
and risk of incident atrial fibrillation in 281 451 primary care patients with a median follow-
up time of 8.4 years.114 Detailed information on heart rate-lowering medications was 
available so that proper adjustment could be done, and adjusted HRs of atrial fibrillation for 
RHRs of 30-51 bpm and of 95-120 bpm compared to a RHR of 66-72 bpm were 1.16 (95% 
CI 1.06 to 1.27) and 1.36 (95% CI 1.26 to 1.46), respectively. However, in the lone atrial 
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fibrillation subgroup analysis (164 064, 58.3% were eligible, 1631 developed lone atrial 
fibrillation) the association was accentuated. A recent meta-analysis on genome-wide 
associations reported that the genetic variants that increase and decrease RHR were 
associated with an increased risk of atrial fibrillation.115 This could explain the strong J-
shaped association between RHR and the risk of lone atrial fibrillation, as genetic reasons for 
atrial fibrillation are more typical among relatively young people without comorbidities. As 
mentioned above, we had a small number of cases of lone atrial fibrillation compared to the 
Copenhagen ECG study. 
Using lone atrial fibrillation as the outcome, Grunndvold et al. also revealed the highest 
incidence rates for atrial fibrillation among healthy middle-aged men with very low or very 
high RHR levels, demonstrating a possible U-shaped relation.116 However, the RHR variable 
was dichotomised (<50 bpm/≥ 50 bpm) in the multivariate Cox regression model, which 
made it impossible to reveal non-linear associations. The authors concluded that low RHR 
(<50 bpm) increases the risk of lone atrial fibrillation in men compared to RHR of 50 bpm or 
higher: adjusted HR 1.69 (95% CI 0.79 to 3.21). 
Considering all this evidence, RHR should be considered an independent risk factor for atrial 
fibrillation. Extremely low RHRs seem to increase the risk of lone atrial fibrillation 
compared to moderate RHRs.110, 114 Elevated RHR seems to increase the risk of both lone 
atrial fibrillation114 and general atrial fibrillation (Paper II), though studies are not 
consistent.110-112 These inconsistencies are most probably due to methods of atrial fibrillation 
ascertainment, and how BP treatment is dealt with. The difference in the associations 
between RHR and lone atrial fibrillation and atrial fibrillation with underlying disorder can 
be explained by the different pathophysiological mechanisms of these types of atrial 
fibrillation. The second type is “substrate related” and occurs due to diseased and dilated 
atria with stretch and fibrosis.113 Lone atrial fibrillation is more related to 
electrophysiological triggers (including genetic factors) in structurally normal atria. 
Our findings demonstrated sex differences in the association between RHR and ischemic 
stroke. We found no independent association in men, and a J-shaped association with 
insignificantly increased risk in extremely low RHR values and a gradually increasing risk 
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with increasing RHRs starting from 70 bpm in women. Most of the other studies on the 
association between RHR and ischemic stroke analysed men and women combined, lacked a 
standardised protocol for RHR measurement, lacked endpoint verification and/or 
classification procedures, or did not adjust for important potential confounders such as 
physical activity and BP.36, 39, 40, 117 None of these studies demonstrated sex differences in 
their associations or J-shaped associations. However, the Women’s Health Initiative study 
reported an independently increased risk of any stroke in women with a RHR higher than 76 
bpm, which is in agreement with our results.39 The Kailuan Study showed that elevated RHR 
is a marker, but not an independent predictor, of ischemic stroke in a study sample that was 
80% male,40 which corresponds to our findings in men. A recent meta-analysis showed that 
the risk of any stroke increased by 5% (95% CI 1 to 8) for every increment in RHR of 10 
bpm in both men and women combined (based on 20 cohort studies); however when RHR 
was categorised (<60 bpm, 60-70 bpm, 70-80 bpm, and >80 bpm) this positive association 
disappeared.33 
The REasons for Geographic And Racial Differences in Stroke study included 24 730 
participants with RHR measured by ECG, had a median follow-up of 7.6 years, and had all 
first-time ischemic stroke events adjudicated by a physician.118 The authors found an 
increased risk of ischemic stroke for each 10 bpm increase in RHR in men and women 
combined: the adjusted HR was 1.10 (95% CI 1.02 to 1.18). The increased risk was observed 
in the middle (61-70 bpm) and upper (>70 bpm) tertiles of RHR compared with the lower 
tertile (<61 bpm): HRs were 1.29 (95% CI 1.06 to 1.57) and 1.37 (95% CI 1.12 to 1.67), 
respectively. However, in a subgroup analysis by sex, the linear association between RHR 
and ischemic stroke in women disappeared: HR for 10 bpm increase in RHR in women was 
1.07 (95% CI 0.97 to 1.19) and 1.12 (95% CI 1.02 to 1.24) in men. This could be evidence of 
a non-linear association between RHR and ischemic stroke in women. Contradictions with 
our findings in men (positive association disappeared after adjustment) could be due to a lack 
of adjustment for physical activity, which is a very important potential confounder.  
Thus, elevated RHR in women increases the risk of ischemic stroke, whereas low RHR levels 
are not beneficial compared to moderate levels. In men, increased RHR is a marker for 
increased risk of ischemic stroke. Several mechanisms can explain the association between 
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RHR and ischemic stroke, and they are similar to those for myocardial infarction: elevated 
RHR is associated with oxidative stress, endothelial dysfunction, and progression of 
atherosclerosis.119, 120 However, atrial fibrillation is a known risk factor for ischemic stroke, 
and it is possible that atrial fibrillation mediates the association between RHR and ischemic 
stroke. As discussed above, low RHR increases the risk of lone atrial fibrillation,110, 114 and 
therefore can increase the risk of subsequent ischemic stroke.  
Our findings are in agreement with a recent, large meta-analysis of prospective cohort studies 
on the association between RHR and all-cause and cardiovascular mortality in the general 
population.32 The authors included 46 studies involving 848 320 participants and 25 800 
cardiovascular deaths, and 1 246 203 participants and 78 349 deaths from all causes. In this 
meta-analysis, elevated RHR independently increased both the risk of all-cause and 
cardiovascular mortality. Compared to the lowest RHR, the multivariate-adjusted relative 
risk of cardiovascular mortality was 1.08 (95% CI 0.99 to 1.17) for those with a RHR of 60-
80 bpm and 1.33 (95% CI 1.19 to 1.47) for those with a RHR of higher than 80 bpm; the 
adjusted relative risk for every 10 bpm increase was 1.08 (95% CI 1.06 to 1.10). For all-
cause mortality the corresponding relative risks were 1.12 (95% CI 1.07 to 1.17), 1.45 (95% 
CI 1.34 to 1.57) and 1.09 (95% CI1.07 to 1.12), respectively. The associations were even 
stronger among participants not taking RHR-lowering medications. The dose-response 
analysis showed that, compared to 45 bpm, the risk of cardiovascular mortality increased 
significantly at 90 bpm, while the risk of all-cause mortality increased significantly with 
increasing RHR in a linear relation. Although the authors did not stratify their analyses by 
sex, their results correspond to ours. We found a strong, positive, gradual association 
between RHR and cardiovascular mortality in men, and between RHR and total mortality in 
both men and women (Paper II). The risk of cardiovascular death in women significantly and 
gradually increased with increasing RHR after 70 bpm. 
Another meta-analysis on the association between RHR and cardiovascular mortality was 
based on 20 studies (all included in the meta-analysis described above).31 Its main findings 
were similar to those of the above-mentioned meta-analysis. The authors conducted a 
subgroup analysis for sex and found a positive association between RHR and the risk of 
cardiovascular mortality in both men and women. However, the association in men was 
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stronger than that in women: the relative risk of cardiovascular mortality for a RHR higher 
than 80 bpm compared to the lowest RHR was 1.60 (95% CI 1.03 to 2.50) in men and 1.41 
(95% CI 1.12 to 1.78) in women. Relative risks for each 10 bpm increase were 1.08 (95% CI 
1.05 to 1.12) in men and 1.03 (95% CI 1.01-1.06) in women. This could be because the 
association between RHR and cardiovascular mortality in women is positive, but not linear: 
low levels of RHR are not protective when compared to moderate levels. That was the case 
in our study, in which we were able to reveal potential non-linear associations and provide 
risk estimates for a wide range of RHR values (Paper II). 
Another recently published study based on a general population without known coronary 
artery disease showed that elevated RHR was an independent predictor of total death, but not 
of incident coronary events (non-fatal myocardial infarction or coronary death) in those 
without heart rate-lowering medication.37 The authors also reported that RHR was not 
associated with total mortality risk in those taking heart rate-lowering medications; however 
mortality rates and coronary event rates were higher among these subjects compared to those 
without hart rate-lowering medications. Thus, heart rate-lowering medications can attenuate 
risk, but not enough to achieve the risk levels of healthy individuals. 
Thus, taken together, our study confirms that RHR is an independent predictor of CVD and 
mortality in both men and women, as reported by others, including the recent meta-analyses. 
However, findings on the associations between RHR and atrial fibrillation and ischemic 
stroke are contradictory. 
4.2.3 Individual long-term changes in resting heart rate and risk of cardiovascular 
disease and death 
Single RHR measures independently predict CVD and mortality. Over the last decades, RHR 
means declined considerably in the general population. Do individual changes in RHR over 
time provide additional information for CVD and mortality risk assessment? There are few 
studies on individual time changes in RHR and their associations with CVD and mortality,121-
124 and most of them121-123 used the difference between two RHR recordings as the measure 
of change in RHR over time.  
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Three studies reported an adverse effect of individual increases in RHR over time on total 
mortality121, 123 and ischemic heart disease mortality122 in the general population, using no 
change in RHR as the reference. However, findings on the effect of RHR decrease over time 
were inconsistent: Jouven et al. found a favourable effect of RHR decrease on total mortality, 
whereas in Hartaig’s paper the effect of RHR decrease on total mortality was not different 
from the effect of stable RHR. Nauman et al. showed insignificant U-shaped association 
between RHR change and ischemic heart disease mortality, with a risk of ischemic heart 
disease that was 1.80 times (95% CI 1.10 to 3.10) higher in those with RHR increases of 
more than 25 bpm and 1.30 (95% CI 0.60 to 2.60) times higher in those with a RHR decrease 
of 25 bpm or more.122 
Jouven et al. included men only;121 whereas Nauman et al. and Hartaigh et al. found no 
interaction between RHR and sex and therefore analysed men and women together.122, 123 All 
three studies used the difference in RHR at two time points as an approximation of temporal 
changes in RHR and adjusted for RHR at baseline. This approach does not provide a 
comprehensive picture of long-term changes in RHR.125, 126 Moreover, there is an interaction 
between RHR at baseline and RHR over time.121, 122 
A recent study analysed the associations between variation in RHR over 4 years and risk of 
incident myocardial infarction and mortality among adults aged 65 years or older.124 The 
RHR of the Cardiovascular Health Study participants was measured by ECG at the first five 
annual study visits. For each participant, linear regression was used to estimate mean, trend 
(the slop), and variation (the SD of the five residuals) in RHR. The authors found that RHR 
mean and variations in RHR, but not trend in RHR were positively associated with mortality 
risk, and none of the RHR variables were associated with myocardial infarction, though the 
number of myocardial infarction events was low. A continuous distribution of RHR trend 
derived from multiple measurements in this study is a better approximation of RHR change 
over time than the difference in RHR at two time points. However it is still not sensitive 
enough to draw a comprehensive picture of RHR change over time. The effect of RHR trend 
was adjusted for RHR mean and variation in RHR, but interaction between RHR trend and 
the other two RHR variables was neither checked nor taken into consideration in the analysis. 
Moreover, the study population was older than in our study and in the studies described 
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above. Limited power, especially for the myocardial infarction analysis, could also be a 
reason why this study failed to replicate the findings of other studies on the association 
between RHR trends and the risk of myocardial infarction or total death. For example, the 
fully adjusted HR of myocardial infarction for RHR trend (2 bpm per year) was 1.08 (95% 
CI 0.95 to 1.23), which is quite high for a 4-year period of RHR change. In comparison, 
fully-adjusted HRs of myocardial infarction for RHR mean (10 bpm) and RHR variation (2 
bpm) were 0.99 (95% CI 0.85 to 1.16) and 1.01 (95% CI 0.90 to 1.14). 
To describe individual long-term trends in RHR, we used three RHR measurements over a 
15-year period and applied latent class models (SAS Proc Traj) to determine RHR trajectory 
groups, and we assigned participants to these groups based on the highest posterior predicted 
probability. This allowed us to avoid the problem of interaction between RHR at baseline or 
at the end of the study period and RHR change over time, as both parameters were taken into 
accounts in the form of trajectories. We found that men with constantly high levels of RHR 
during adulthood were at the highest risk of myocardial infarction and total death. Another 
RHR trajectory with adverse effect on cardiovascular death and total death in men was 
having an RHR that increased over the years. Men with consistently low RHR levels had the 
lowest risk. We did not observe any independent associations in women, but this is most 
probably due to limited power, as the point estimates for myocardial infarction and total 
death in women were similar to those in men. Point estimates for a decrease from high to 
moderate levels RHR trajectory were similar to point estimates for a trajectory with 
constantly moderate RHR levels, and were not significantly different from the low RHR 
trajectory in both men and women. 
Thus, our findings correspond well with Mannsverk’s findings on the important role of RHR 




Chapter 5 Conclusion and future research 
RHR mean values declined over the last decades in the general population, which 
corresponds well with positive trends in cardiovascular morbidity and mortality. At the same 
time, the decline could not be explained by individual changes in traditional cardiovascular 
risk factors. Moreover, RHR itself and individual long-term changes in RHR independently 
predict CVD and mortality in both men and women. These findings suggest that RHR must 
be considered as a major cardiovascular risk factor. As RHR is a simple and easily measured 
cardiovascular parameter, it can be used to monitor CVD risk. 
As over the last decades, RHR declined substantially in the general population, thus new 
definitions of normal RHR may be needed, and the reasons behind the decline in RHR in the 
general population need to be further elucidated. Increased use of beta blockers and calcium 
channel blockers for reasons other than hypertension, use of selective If inhibitors, and 
increased use of lipid-lowering drugs should be explored in further studies as possible 
explanations of the RHR decline. Though there is enough evidence on independent 
associations of RHR with myocardial infarction, cardiovascular mortality and total mortality, 
associations of RHR with other outcomes need to be clarified. The association between RHR 
and the risk of atrial fibrillation and ischemic stroke in the general population needs to be 
further investigated. The effect of low RHR levels on the risk of atrial fibrillation in men and 
on the risk of ischemic stroke in women, as well as the independent association between 
RHR and ischemic stroke in men, are of particular interest. As RHR is a modifiable 
parameter, it may  be possible to use it for CVD prevention. However, studies (including 
randomised control trials) on the effect of RHR-lowering interventions such as lifestyle 
interventions and RHR-lowering drugs on CVD and mortality risk in the general populations 
are warranted. A prediction algorithm needs to be developed to consider RHR, individual 
change in RHR, and traditional cardiovascular risk factors in order to allow clinicians to use 
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